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LINDSEY	  MARTIN	  WEBB	  
Impact	  of	  Insurance	  Status	  on	  Childhood	  Immunization	  Uptake	  
 Economic	  barriers	  remain	  an	  obstacle	  to	  ensuring	  that	  children	  in	  the	  United	  States	  are	  protected	  against	  vaccine-­‐preventable	  diseases.	  Disparities	  persist	  despite	  programs	  in	  place	  to	  alleviate	  them,	  such	  as	  the	  Vaccines	  for	  Children	  program,	  which	  provides	  free	  vaccines	  for	  eligible	  children.	  	  Using	  data	  from	  the	  2010	  National	  Immunization	  Survey,	  this	  study	  addresses	  whether	  insurance	  status	  has	  an	  impact	  on	  immunization	  uptake	  by	  investigating	  associations	  between	  vaccine	  receipt	  and	  insurance	  type,	  VFC	  eligibility,	  and	  insurance	  continuity.	  	  Logistic	  regression	  was	  performed	  using	  possible	  important	  factors	  suggested	  in	  the	  literature.	  	  Among	  children	  in	  the	  national	  sample,	  results	  showed	  strong	  associations	  between	  up-­‐to-­‐date	  immunization	  status	  and	  insurance	  type,	  VFC	  eligibility,	  and	  insurance	  continuity,	  suggesting	  that	  additional	  steps	  must	  be	  taken	  to	  alleviate	  disparities	  in	  vaccine	  receipt.	  	  Regression	  analysis	  showed	  child’s	  age	  group,	  insurance	  continuity,	  and	  number	  of	  vaccine	  providers	  to	  be	  the	  strongest	  predictors	  of	  up-­‐to-­‐date	  status	  among	  children	  in	  the	  national	  sample.	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1.1	  Background	  Since	  the	  development	  of	  the	  first	  vaccine	  over	  200	  years	  ago,	  immunizations	  have	  had	  a	  tremendous	  impact	  on	  human	  populations	  by	  greatly	  reducing	  the	  morbidity	  and	  mortality	  associated	  with	  infectious	  diseases.	  	  Of	  the	  diseases	  for	  which	  vaccines	  have	  been	  recommended	  for	  use	  in	  all	  children	  in	  the	  United	  States	  (US),	  smallpox	  has	  been	  eradicated,	  and	  polio	  caused	  by	  wild-­‐type	  viruses	  has	  been	  eliminated	  from	  the	  Western	  Hemisphere.	  	  Others,	  including	  measles,	  rubella,	  and	  Haemophilus	  influenzae	  type	  b	  (Hib)	  have	  been	  reduced	  to	  just	  a	  few	  cases	  in	  children	  annually.	  	  For	  these	  reasons,	  vaccines	  have	  been	  called	  “one	  of	  the	  greatest	  achievements	  of	  biomedical	  science	  and	  public	  health	  (CDC,	  1999).”	  	  
Immunizations	  in	  the	  United	  States	  Despite	  the	  advances,	  however,	  vaccine-­‐preventable	  diseases	  still	  occur	  in	  the	  United	  States,	  and	  several	  challenges	  remain	  in	  ensuring	  that	  children	  are	  protected	  against	  them.	  	  Healthy	  People	  2020	  lists	  increasing	  childhood	  immunization	  rates	  as	  one	  of	  its	  goals;	  specifically,	  to	  “achieve	  and	  maintain	  effective	  vaccination	  coverage	  levels	  for	  universally	  recommended	  vaccines	  among	  young	  children	  (DHHS).”	  	  Although	  national	  immunization	  coverage	  rates	  are	  high,	  it	  is	  important	  to	  overcome	  obstacles	  to	  ensuring	  that	  these	  rates	  remain	  as	  high	  as	  possible.	  	  Infectious	  diseases	  persist	  in	  many	  countries	  globally,	  and	  can	  be	  imported	  into	  the	  US,	  threatening	  unprotected	  persons	  (CDC,	  1999).	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For	  example,	  the	  US	  and	  other	  developed	  areas	  where	  measles	  was	  once	  eliminated	  have	  experienced	  a	  resurgence	  in	  cases	  of	  the	  disease	  due	  to	  declining	  immunization	  rates.	  	  The	  US	  has	  seen	  multiple	  outbreaks	  of	  measles	  in	  unvaccinated	  school-­‐age	  children	  since	  2008.	  	  In	  the	  first	  six	  months	  of	  2008,	  the	  number	  of	  reported	  measles	  cases	  was	  131;	  almost	  a	  100	  percent	  increase	  over	  the	  yearly	  average	  for	  previous	  years,	  despite	  the	  fact	  that	  the	  measles	  vaccine	  is	  required	  for	  most	  children	  entering	  public	  schools.	  	  Some	  of	  these	  cases	  were	  imported	  from	  other	  countries,	  but	  post-­‐importation	  transmission	  accounted	  for	  most	  of	  the	  increase	  in	  cases	  over	  previous	  years	  (CDC,	  2008a).	  	  Public	  health	  professionals	  must	  also	  consider	  ever-­‐changing	  public	  views	  of	  vaccines,	  which	  range	  from	  supportive	  to	  fearful;	  and	  regulations	  and	  the	  expenses	  of	  creating	  and	  testing	  vaccines	  can	  cause	  pharmaceutical	  companies	  to	  eschew	  their	  development	  (Stern	  &	  Markel,	  2005).	  	  Also,	  there	  are	  economic	  barriers	  to	  having	  children	  immunized,	  which	  means	  that	  children	  in	  poverty	  or	  without	  insurance	  are	  less	  likely	  than	  others	  to	  receive	  the	  full	  complement	  of	  recommended	  vaccines	  (Zimmerman,	  et	  al.,	  2006).	  According	  to	  Healthy	  People	  2020,	  some	  childhood	  immunization	  objective	  targets	  have	  been	  met	  for	  children	  19	  to	  35	  months	  of	  age,	  and	  the	  current	  goal	  is	  to	  maintain	  the	  target	  national	  immunization	  rates.	  	  Target	  rates	  have	  been	  reached	  for	  children	  having	  three	  doses	  of	  hepatitis	  B	  vaccine,	  one	  dose	  of	  the	  measles-­‐mumps-­‐rubella	  (MMR)	  vaccine,	  three	  doses	  of	  polio	  vaccine,	  and	  one	  dose	  of	  the	  varicella	  vaccine	  by	  age	  19	  to	  35	  months.	  	  Objective	  targets	  which	  still	  must	  be	  achieved	  include	  having	  four	  doses	  of	  the	  diphtheria-­‐tetanus-­‐acellular-­‐pertussis	  (DTaP)	  vaccine,	  three	  doses	  of	  the	  Hib	  vaccine,	  four	  doses	  of	  the	  pneumococcal	  conjugate	  vaccine	  (PCV),	  two	  doses	  of	  the	  hepatitis	  A	  vaccine,	  and	  two	  or	  more	  doses	  of	  rotavirus	  vaccine	  by	  age	  19	  to	  35	  months;	  as	  well	  as	  a	  birth	  dose	  of	  the	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hepatitis	  B	  vaccine.	  	  Although	  only	  0.6	  percent	  of	  children	  19	  to	  35	  months	  old	  in	  the	  US	  had	  received	  no	  doses	  of	  recommended	  vaccines	  in	  2008,	  only	  68	  percent	  of	  children	  in	  that	  age	  group	  had	  received	  the	  full	  recommended	  doses	  of	  DTaP,	  polio,	  MMR,	  Hib,	  hepatitis	  B,	  PCV,	  and	  varicella	  vaccines	  (DHHS).	  	  
Insurance	  and	  Programs	  that	  Cover	  Vaccines	  Health	  insurance	  in	  the	  US	  is	  usually	  either	  classified	  as	  public	  or	  private.	  	  Private	  insurance	  is	  considered	  to	  be	  that	  which	  is	  purchased	  through	  an	  employer	  or	  union,	  and	  those	  insurance	  plans	  purchased	  directly	  from	  an	  insurance	  company.	  	  Public	  health	  insurance	  programs	  are	  those	  sponsored	  by	  the	  government.	  	  These	  include	  Medicare,	  for	  people	  over	  65	  years	  old	  or	  disabled;	  Medicaid,	  a	  means-­‐tested	  program	  for	  those	  with	  low	  income;	  the	  Indian	  Health	  Service,	  for	  American	  Indians	  and	  Alaska	  Natives;	  the	  Military	  Health	  System,	  for	  active	  duty	  and	  retired	  military	  members	  and	  their	  families;	  and	  the	  State	  Children’s	  Health	  Insurance	  Program	  (SCHIP),	  which	  was	  created	  in	  1997	  and	  covers	  lower-­‐income	  families	  whose	  incomes	  are	  too	  high	  to	  qualify	  for	  Medicaid.	  The	  percentage	  of	  people	  covered	  by	  private	  insurance	  has	  been	  decreasing	  since	  2001.	  	  Those	  with	  public	  health	  insurance	  programs	  rather	  than	  private	  insurance	  increased	  by	  almost	  2	  million	  people	  from	  2009	  to	  2010;	  in	  2010,	  31%	  of	  Americans	  were	  covered	  by	  public	  health	  insurance.	  	  Despite	  these	  public	  insurance	  programs	  to	  assist	  those	  who	  are	  unable	  to	  have	  privately	  purchased	  insurance	  or	  health	  insurance	  plans	  through	  their	  employer,	  16.3	  percent	  of	  people	  in	  the	  US	  lack	  any	  kind	  of	  health	  insurance.	  	  Among	  children	  under	  age	  18	  in	  the	  US,	  9.8	  percent	  were	  uninsured	  in	  2010,	  with	  the	  majority	  of	  uninsured	  children	  being	  those	  living	  in	  poverty	  (U.S.	  Census	  Bureau,	  2010).	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The	  Vaccines	  for	  Children	  (VFC)	  program,	  implemented	  in	  1994	  following	  the	  1989-­‐1991	  US	  measles	  epidemic,	  provides	  free	  vaccines	  to	  health	  care	  providers	  for	  children	  who	  may	  not	  otherwise	  have	  access	  to	  vaccines.	  	  Children	  are	  eligible	  for	  the	  VFC	  program	  if	  they	  are	  Medicaid	  eligible,	  uninsured,	  American	  Indian	  or	  Alaska	  Native,	  or	  underinsured.	  	  The	  VFC	  program	  defines	  an	  underinsured	  child	  as	  “a	  child	  who	  has	  commercial	  (private)	  health	  insurance	  but	  the	  coverage	  does	  not	  include	  vaccines,	  a	  child	  whose	  insurance	  covers	  only	  selected	  vaccines,	  or	  a	  child	  whose	  insurance	  caps	  vaccine	  coverage	  at	  a	  certain	  amount	  (CDC,	  2011a)”.	  	  
1.2	  Purpose	  of	  Study	  It	  is	  important	  to	  maintain	  appropriate	  immunization	  rates.	  	  Without	  routine	  childhood	  immunization,	  morbidity	  and	  mortality	  caused	  by	  vaccine-­‐preventable	  diseases	  would	  rise.	  	  Also	  associated	  with	  infectious	  diseases	  are	  lost	  productivity	  costs	  for	  parents	  and	  caretakers,	  and	  healthcare	  costs	  for	  families	  as	  well	  as	  health	  care	  providers	  (Chen,	  et	  al.,	  2011).	  	  In	  some	  areas	  of	  the	  world,	  a	  decline	  in	  immunization	  rates	  has	  led	  to	  the	  reemergence	  of	  infectious	  diseases,	  as	  has	  occurred	  with	  measles	  in	  Europe	  and	  pertussis	  in	  Japan	  (CDC,	  2008a;	  CDC,	  2011b).	  	  Maintaining	  appropriate	  vaccination	  rates	  also	  protects	  those	  children	  who	  are	  not	  old	  enough	  to	  receive	  vaccinations	  and	  those	  who	  cannot	  for	  medical	  reasons	  (CDC,	  2008a).	  Economic	  barriers	  remain	  an	  obstacle	  to	  ensuring	  that	  children	  are	  protected	  against	  vaccine-­‐preventable	  diseases	  (Zimmerman,	  et	  al.,	  2006).	  In	  the	  United	  States,	  children	  in	  poverty	  are	  more	  likely	  to	  be	  uninsured	  (U.S.	  Census	  Bureau,	  2010).	  	  Children	  living	  below	  the	  poverty	  line	  are	  also	  less	  likely	  to	  receive	  routine	  immunizations	  than	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more	  affluent	  children,	  a	  trend	  that	  has	  persisted	  despite	  programs	  in	  place	  to	  alleviate	  the	  disparity	  (Zimmerman,	  et	  al.,	  2006;	  Smith,	  Stevenson,	  &	  Chu,	  2006).	  	  	  As	  Medicaid	  has	  been	  available	  for	  quite	  some	  time	  for	  people	  with	  low	  income	  who	  are	  unable	  to	  purchase	  private	  insurance,	  this	  gap	  should	  be	  gradually	  closing.	  	  Additionally,	  the	  implementation	  of	  the	  Vaccines	  for	  Children	  program	  in	  1994	  and	  the	  State	  Children’s	  Health	  Insurance	  Program	  in	  1997	  should	  be	  further	  alleviating	  the	  disparities	  in	  immunization	  coverage.	  	  	  The	  purpose	  of	  this	  study	  is	  to	  address	  whether	  insurance	  status	  has	  an	  effect	  on	  immunization	  uptake,	  by	  investigating	  associations	  between	  vaccine	  receipt	  and	  insurance	  type,	  Vaccines	  for	  Children	  eligibility,	  and	  insurance	  continuity.	  	  	  	  
1.3	  Research	  Questions	  	  1. Is	  there	  an	  association	  between	  insurance	  type	  and	  immunization	  status? 
 
 2. Is	  there	  an	  association	  between	  Vaccines	  for	  Children	  eligibility	  and	  immunization	  status? 
 
 3. Is	  there	  an	  association	  between	  immunization	  status	  and	  continuity	  of	  health	  insurance? 
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4. Which	  of	  the	  selected	  factors,	  chosen	  based	  on	  the	  literature,	  are	  most	  important	  in	  determining	  up-­‐to-­‐date	  immunization	  status? child’s	  age	  group	   	   	   	   child’s	  race/ethnicity	  mother’s	  education	   	   	   	   mother’s	  marital	  status	  household	  poverty	  status	   	   	   insurance	  type	  insurance	  continuity	  	   	   	   number	  of	  vaccine	  providers	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CHAPTER	  II	  
REVIEW	  OF	  THE	  LITERATURE	  
 	   The	  purpose	  of	  this	  study	  is	  to	  address	  whether	  insurance	  status	  has	  an	  effect	  on	  immunization	  uptake.	  	  A	  review	  of	  the	  literature	  discusses	  recommended	  vaccines	  and	  immunization	  requirements,	  goals	  and	  progress	  to	  date	  on	  immunization	  rates,	  consequences	  of	  declining	  immunization	  rates,	  and	  possible	  barriers	  to	  immunization.	  	  Additional	  literature	  has	  investigated	  the	  relationship	  between	  insurance	  status	  and	  immunization	  uptake	  and	  has	  sought	  to	  determine	  the	  impact	  of	  the	  SCHIP	  and	  VFC	  programs.	  
 
2.1	  Immunizations	  in	  the	  United	  States	  
 In	  the	  United	  States,	  the	  government	  has	  been	  involved	  in	  immunizations	  since	  the	  1800s	  with	  the	  use	  of	  the	  smallpox	  vaccine.	  	  In	  1885,	  Massachusetts	  passed	  the	  first	  law	  in	  the	  US	  mandating	  vaccination	  of	  children	  in	  schools	  (CPP,	  2011).	  	  Little	  more	  than	  one	  hundred	  years	  ago,	  the	  mortality	  rate	  for	  children	  under	  five	  years	  old	  was	  a	  staggering	  twenty	  percent;	  infectious	  diseases	  that	  are	  now	  vaccine-­‐preventable	  were	  among	  the	  most	  common	  causes	  of	  child	  mortality.	  	  Today,	  many	  of	  these	  diseases	  have	  been	  contained	  in	  the	  US	  due	  to	  the	  use	  of	  vaccines	  and	  immunization	  requirements	  (Stern	  &	  Markel,	  2005).	  	  Children	  are	  required	  to	  have	  received	  certain	  immunizations	  (or	  must	  apply	  for	  and	  receive	  an	  exemption)	  in	  order	  to	  be	  enrolled	  in	  public	  schools.	  	  Though	  the	  requirements	  differ	  slightly	  from	  state	  to	  state,	  most	  states	  generally	  use	  the	  childhood	  immunization	  schedule	  recommended	  by	  the	  Centers	  for	  Disease	  Control	  and	  Prevention	  	  [see	  table	  1	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(DHHS,	  2011)]	  when	  mandating	  childhood	  vaccines	  (NVPO,	  2011).	  	  Georgia,	  for	  example,	  requires	  proof	  of	  receipt	  of	  certain	  vaccines	  for	  children	  entering	  any	  day	  care	  facility;	  those	  enrolled	  in	  Head	  Start,	  the	  state	  pre-­‐kindergarten	  program;	  and	  those	  enrolled	  in	  public	  elementary,	  middle,	  and	  high	  schools.	  	  Georgia	  does	  not,	  however,	  require	  children	  to	  have	  received	  the	  rotavirus,	  meningococcal,	  or	  influenza	  vaccines	  for	  school	  enrollment	  (National	  Network	  for	  Immunization	  Information,	  2007).	  
	  
Table	  1.	  Recommended	  immunization	  schedule	  for	  persons	  aged	  0	  through	  6	  years,	  2011	  
(DHHS,	  2011)	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2.2	  Vaccines,	  Goals	  and	  Progress	  Healthy	  People,	  a	  set	  of	  10-­‐year	  national	  health	  objectives	  intended	  to	  encourage	  collaboration,	  inform	  health	  decisions,	  and	  measure	  the	  impact	  of	  prevention	  activities,	  has	  listed	  targets	  for	  immunization	  coverage	  rates	  in	  the	  US	  since	  its	  first	  publication,	  Healthy	  People	  2000,	  in	  1990	  (DHHS).	  	  In	  the	  US,	  there	  are	  17	  infectious	  diseases	  for	  which	  vaccines	  are	  currently	  recommended;	  here	  the	  focus	  is	  on	  those	  pertaining	  to	  Healthy	  People	  2020	  immunization	  coverage	  targets	  for	  children	  aged	  19	  to	  35	  months.	  	  In	  2008,	  68	  percent	  of	  children	  aged	  19	  to	  35	  months	  had	  received	  the	  recommended	  doses	  of	  the	  DTaP,	  polio,	  MMR,	  Hib,	  hepatitis	  B,	  varicella,	  and	  PCV	  vaccines;	  the	  goal	  is	  to	  increase	  this	  to	  80	  percent	  by	  2020	  (DHHS).	  	  However,	  coverage	  in	  the	  US	  was	  much	  higher	  for	  the	  older	  vaccines,	  such	  as	  the	  polio	  vaccine	  which	  has	  been	  in	  use	  for	  decades,	  than	  it	  was	  for	  more	  recently	  introduced	  vaccines	  such	  as	  varicella	  and	  for	  newer	  vaccine	  series	  (CDC,	  1999).	  	  
Haemophilus	  Influenzae	  Type	  B	  
 Haemophilus	  influenzae	  type	  b	  (Hib)	  is	  a	  bacterial	  disease	  that	  most	  often	  causes	  serious	  illness	  in	  children	  less	  than	  five	  years	  of	  age.	  	  Hib	  infection	  can	  lead	  to	  pneumonia,	  difficulty	  breathing	  due	  to	  swollen	  throat,	  and	  infections	  of	  the	  blood,	  joints,	  bones,	  and	  covering	  of	  the	  heart.	  	  Before	  the	  introduction	  of	  the	  disease,	  Hib	  was	  the	  leading	  cause	  of	  bacterial	  meningitis	  in	  young	  children	  in	  the	  US,	  which	  can	  lead	  to	  permanent	  impairments,	  such	  as	  hearing	  loss	  or	  mental	  retardation,	  and	  death.	  	  Hib	  is	  most	  commonly	  transmitted	  via	  the	  bacteria	  entering	  the	  respiratory	  system.	  	  Asymptomatic	  carriers	  of	  Hib	  can	  perpetuate	  transmission.	  	  Approximately	  1,000	  children	  per	  year	  died	  from	  complications	  of	  Hib	  infection	  before	  the	  introduction	  of	  the	  vaccine	  (CDC,	  1998;	  Nelson	  &	  Williams,	  
	   10	  
2007).	  	  The	  Hib	  vaccine	  is	  given	  as	  a	  series	  of	  three	  or	  four	  shots,	  at	  the	  recommended	  ages	  of	  two	  months	  of	  age,	  four	  months	  of	  age,	  six	  months	  of	  age,	  and	  twelve	  to	  fifteen	  months	  of	  age.	  	  The	  vaccine	  is	  rarely	  given	  to	  individuals	  over	  five	  years	  of	  age	  (CDC,	  1998).	  	  In	  Georgia,	  the	  Hib	  vaccine	  is	  required	  for	  entry	  into	  daycare	  and	  pre-­‐kindergarten,	  but	  is	  not	  required	  for	  children	  entering	  any	  other	  grades	  in	  the	  public	  school	  system	  (National	  Network	  for	  Immunization	  Information,	  2007).	  	   Healthy	  People	  2020	  lists	  a	  goal	  of	  90	  percent	  of	  children	  in	  the	  US	  receiving	  three	  doses	  of	  the	  Hib	  vaccine	  by	  19	  to	  35	  months	  of	  age.	  	  In	  2009,	  however,	  only	  57	  percent	  of	  children	  in	  this	  age	  group	  had	  received	  the	  recommended	  number	  of	  doses,	  so	  efforts	  must	  be	  continued	  and	  strengthened	  to	  achieve	  the	  objective	  (DHHS).	  	  Despite	  the	  relatively	  low	  immunization	  coverage,	  however,	  invasive	  Hib	  disease	  incidence	  in	  young	  children	  in	  the	  US	  has	  decrease	  by	  99%,	  and	  it	  may	  be	  possible	  to	  eliminate	  endemic	  transmission	  of	  Hib	  in	  the	  country	  (Nelson	  &	  Williams,	  2007).	  
 
Hepatitis	  A	  
 Hepatitis	  A	  is	  a	  liver	  disease	  caused	  by	  the	  hepatitis	  A	  virus,	  which	  can	  be	  spread	  through	  contact	  with	  infected	  persons	  and	  eating	  food	  or	  drinking	  water	  contaminated	  with	  the	  virus.	  	  Hepatitis	  A	  can	  cause	  acute	  flu-­‐like	  symptoms,	  jaundice,	  severe	  stomach	  pains	  and	  diarrhea;	  approximately	  one	  in	  five	  individuals	  with	  hepatitis	  A	  must	  be	  hospitalized	  (CDC,	  2006a).	  	  There	  is	  no	  evidence	  that	  hepatitis	  A	  causes	  chronic	  illness.	  	  Severity	  is	  often	  inversely	  associated	  with	  age,	  but	  the	  hepatitis	  vaccine	  can	  confer	  long-­‐term	  protection	  when	  two	  doses	  are	  given	  (Nelson	  &	  Williams,	  2007).	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 Hepatitis	  B	  is	  a	  viral	  disease	  that	  affects	  the	  liver	  and	  can	  cause	  both	  acute	  and	  chronic	  illness.	  	  Acute	  symptoms	  include	  loss	  of	  appetite,	  fatigue,	  jaundice,	  diarrhea,	  vomiting,	  and	  muscle,	  joint,	  and	  stomach	  pain.	  	  Chronic	  symptoms	  include	  cirrhosis	  and	  liver	  cancer	  and	  can	  lead	  to	  death.	  	  Hepatitis	  B	  is	  transmitted	  through	  contact	  with	  infected	  blood	  or	  bodily	  fluids.	  	  In	  2005,	  there	  were	  about	  51,000	  new	  hepatitis	  b	  infections,	  and	  approximately	  1.25	  million	  Americans	  have	  chronic	  hepatitis	  b;	  however,	  since	  routine	  immunization	  began	  in	  1991,	  hepatitis	  b	  incidence	  has	  decreased	  by	  more	  than	  95%.	  	  The	  hepatitis	  b	  vaccine	  is	  given	  as	  a	  series	  of	  three	  or	  four	  shots,	  the	  first	  of	  which	  should	  be	  given	  at	  birth	  and	  the	  last	  of	  which	  should	  be	  given	  by	  six	  to	  eighteen	  months	  of	  age.	  	  Those	  not	  given	  the	  vaccine	  during	  the	  recommended	  time	  frame	  should	  receive	  it	  as	  soon	  as	  possible	  (CDC,	  2007).	  	   The	  target	  immunization	  coverage	  rate	  is	  90	  percent	  for	  three	  doses	  of	  the	  hepatitis	  b	  vaccine	  by	  age	  19	  to	  35	  months.	  	  In	  2008,	  94	  percent	  of	  children	  in	  that	  age	  range	  had	  received	  the	  recommended	  immunization;	  the	  Healthy	  People	  2020	  goal	  is	  to	  maintain	  this	  high	  rate	  of	  coverage.	  	  There	  is	  a	  second	  objective	  associated	  with	  hepatitis	  b	  immunization:	  a	  birth	  dose	  should	  be	  given	  to	  infants	  within	  three	  days	  of	  birth.	  	  The	  target	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coverage	  rate	  for	  the	  birth	  dose	  is	  85	  percent;	  in	  2005,	  just	  51	  percent	  of	  infants	  born	  in	  2005	  received	  the	  vaccine	  within	  three	  days	  (DHHS).	  	  	  
 
Measles-­‐Mumps-­‐Rubella	  
 The	  measles-­‐mumps-­‐rubella	  (MMR)	  vaccine	  protects	  against	  the	  airborne	  viruses	  that	  cause	  the	  three	  diseases.	  	  Measles	  is	  a	  highly	  contagious	  respiratory	  disease	  that	  causes	  rash,	  cough,	  runny	  nose,	  and	  fever,	  and	  can	  lead	  to	  ear	  infections,	  pneumonia,	  seizures,	  encephalitis,	  blindness,	  and	  death.	  	  Mumps	  is	  characterized	  by	  fever	  and	  swollen	  glands,	  but	  can	  also	  lead	  to	  deafness,	  meningitis,	  encephalitis,	  orchitis,	  and	  death.	  	  Rubella,	  sometimes	  called	  German	  measles,	  causes	  rash	  and	  mild	  fever,	  and	  can	  cause	  congenital	  rubella	  syndrome	  (CRS)	  in	  infants	  whose	  mothers	  contract	  rubella	  while	  pregnant.	  	  CRS	  can	  lead	  to	  deafness	  and	  other	  birth	  defects	  (CDC,	  2008d).	  	   The	  Healthy	  People	  2020	  goal	  for	  MMR	  vaccine	  coverage	  is	  one	  dose	  for	  90	  percent	  of	  children	  in	  the	  19	  to	  35	  month	  age	  range.	  	  In	  2008,	  92	  percent	  in	  that	  age	  group	  had	  received	  one	  dose	  of	  the	  MMR	  vaccine	  (DHHS).	  	  However,	  it	  has	  been	  noted	  that	  a	  minimum	  95	  percent	  measles	  immunization	  coverage	  rate	  is	  essential	  to	  ensure	  herd	  immunity	  against	  that	  disease.	  	  Therefore,	  it	  may	  become	  necessary	  to	  further	  increase	  coverage	  rates	  of	  the	  MMR	  vaccine	  in	  order	  to	  fully	  protect	  the	  population	  from	  measles	  (Nagaraj,	  2006).	  
 
Pneumococcal	  Conjugate	  Vaccine	  
 The	  pneumococcal	  conjugate	  vaccine	  (PCV)	  protects	  against	  infection	  with	  
Streptococcus	  pneumoniae	  bacteria,	  which	  causes	  blood	  infections,	  meningitis,	  and	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pneumonia.	  	  Pneumococcal	  infection	  is	  rare,	  but	  can	  cause	  severe	  morbidity	  and	  is	  fatal	  in	  approximately	  ten	  percent	  of	  cases.	  	  There	  are	  more	  than	  90	  types	  of	  pneumococcal	  bacteria;	  the	  current	  PCV,	  in	  use	  since	  2000,	  offers	  immunity	  against	  13	  strains.	  	  The	  previous	  PCV	  protected	  against	  seven	  types	  of	  pneumococcal	  bacteria;	  since	  the	  newer	  vaccine	  was	  introduced,	  incidence	  of	  severe	  pneumococcal	  disease	  in	  children	  less	  than	  five	  years	  of	  age	  decreased	  by	  almost	  80	  percent.	  	  PCV	  is	  intended	  to	  be	  given	  as	  a	  series	  of	  four	  shots;	  one	  each	  at	  age	  two	  months,	  four	  months,	  six	  months,	  and	  twelve	  to	  fifteen	  months	  (CDC,	  2010a).	  	  The	  pneumococcal	  conjugate	  vaccine	  is	  generally	  given	  to	  infants,	  as	  very	  young	  children	  are	  at	  the	  greatest	  risk	  of	  serious	  illness	  and	  death;	  risk	  of	  severe	  illness	  decreases	  with	  increased	  age	  (DHHS).	  	   The	  target	  immunization	  coverage	  for	  PCV	  is	  four	  doses	  by	  age	  19	  to	  35	  months	  for	  90	  percent	  of	  children	  in	  the	  US.	  	  In	  2008,	  80	  percent	  of	  children	  in	  that	  age	  group	  had	  received	  all	  four	  recommended	  doses	  of	  the	  vaccine	  (DHHS).	  	  As	  pneumococcal	  disease	  most	  commonly	  affects	  children	  under	  five	  years	  of	  age,	  the	  vaccine	  is	  not	  always	  required	  for	  entry	  into	  the	  public	  school	  system,	  but	  can	  be	  required	  for	  younger	  children	  enrolling	  in	  daycare	  or	  pre-­‐kindergarten	  programs	  (National	  Network	  for	  Immunization	  Information,	  2007).	  
 
Polio	  
 The	  inactivated	  polio	  vaccine	  (IPV)	  protects	  against	  poliomyelitis,	  or	  polio,	  which	  is	  caused	  by	  poliovirus.	  	  Polio	  can	  be	  asymptomatic	  or	  can	  lead	  to	  paralysis	  and	  death.	  	  After	  the	  polio	  vaccine	  was	  introduced	  in	  1955,	  incidence	  declined	  to	  the	  point	  that	  endemic	  transmission	  of	  wild-­‐type	  poliovirus	  was	  declared	  eliminated	  in	  the	  US	  in	  1979	  (CDC,	  2000;	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Nelson	  &	  Williams,	  2007).	  	  Two	  polio	  vaccines	  exist,	  IPV	  and	  the	  oral	  live	  attenuated	  vaccine	  (OPV),	  but	  only	  IPV	  is	  recommended	  for	  use	  in	  areas	  in	  which	  endemic	  polio	  transmission	  has	  been	  eliminated.	  	  The	  polio	  vaccine	  is	  given	  as	  a	  series	  of	  four	  shots;	  one	  each	  at	  age	  two	  months,	  four	  months,	  six	  to	  eighteen	  months,	  and	  a	  booster	  at	  four	  to	  six	  years	  (CDC,	  2000).	  	   Healthy	  People	  2020	  lists	  a	  target	  immunization	  rate	  of	  90	  percent	  of	  children	  receiving	  three	  doses	  of	  the	  polio	  vaccine	  by	  age	  19	  to	  35	  months;	  in	  2008,	  94	  percent	  of	  children	  in	  that	  age	  group	  had	  received	  the	  recommended	  number	  of	  doses	  (DHHS).	  	  High	  immunization	  coverage	  must	  be	  maintained,	  as	  polio	  is	  still	  common	  in	  many	  parts	  of	  the	  world,	  and	  can	  be	  imported	  into	  areas	  where	  endemic	  transmission	  no	  longer	  exists	  (CDC,	  2000).	  
 
Rotavirus	  
 Rotavirus	  is	  one	  of	  the	  most	  serious	  causes	  of	  diarrheal	  disease	  in	  young	  children.	  	  Other	  symptoms	  include	  vomiting,	  fever,	  and	  dehydration.	  	  Before	  the	  introduction	  of	  the	  rotavirus	  vaccine	  in	  2006,	  almost	  all	  US	  children	  were	  infected	  with	  rotavirus	  before	  the	  age	  of	  five.	  	  The	  rotavirus	  vaccine	  protects	  children	  against	  most	  cases	  of	  rotavirus,	  and	  almost	  always	  prevents	  severe	  rotavirus	  illness.	  	  The	  vaccine	  is	  oral	  rather	  than	  injected,	  and	  given	  as	  a	  series	  of	  either	  two	  of	  three	  doses,	  depending	  on	  the	  brand.	  	  A	  dose	  is	  recommended	  at	  two	  months	  of	  age,	  four	  months	  of	  age,	  and	  six	  months	  of	  age	  if	  a	  third	  dose	  is	  necessary	  (CDC,	  2010b).	  	  	  	   The	  Healthy	  People	  2020	  rotavirus	  goal	  is	  for	  at	  least	  80	  percent	  of	  children	  to	  receive	  at	  least	  two	  doses	  of	  the	  rotavirus	  vaccine	  by	  age	  19	  to	  35	  months.	  	  In	  2009,	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approximately	  38	  percent	  of	  children	  in	  that	  age	  group	  had	  received	  the	  recommended	  doses	  (DHHS).	  	  The	  relatively	  low	  immunization	  coverage	  could	  be	  at	  least	  partially	  attributed	  to	  the	  recent	  introduction	  of	  the	  vaccine,	  as	  well	  as	  to	  the	  fact	  that	  the	  vaccine	  is	  not	  mandated	  by	  all	  states	  (National	  Network	  for	  Immunization	  Information,	  2007).	  	  However,	  recent	  research	  has	  shown	  that	  immunization	  against	  rotavirus	  has	  greatly	  reduced	  health	  care	  and	  treatment	  costs	  for	  diarrheal	  disease	  in	  young	  children	  in	  the	  US.	  	  Vaccinated	  children	  were	  shown	  to	  have	  44	  to	  58	  fewer	  diarrhea-­‐related	  hospitalizations	  and	  37	  to	  48	  fewer	  related	  emergency	  department	  visits	  than	  children	  not	  vaccinated	  against	  rotavirus.	  	  Researchers	  estimate	  that	  65,000	  diarrhea-­‐related	  hospitalizations	  were	  averted	  in	  the	  US	  from	  2007	  to	  2009,	  saving	  about	  $278	  million	  in	  health	  care	  costs	  (CDC,	  2011c).	  
 
DTaP	  	   The	  Diphtheria-­‐Tetanus-­‐acellular	  Pertussis	  (DTaP)	  vaccine	  protects	  against	  infection	  with	  bacteria	  that	  cause	  tetanus,	  diphtheria,	  and	  pertussis.	  	  Pertussis,	  or	  whooping	  cough,	  is	  spread	  from	  person	  to	  person	  and	  causes	  severe	  coughing	  spells,	  vomiting,	  and	  disrupted	  sleep.	  	  The	  violent	  coughing	  can	  lead	  to	  weight	  loss,	  incontinence,	  and	  rib	  fractures.	  	  Hospitalization	  is	  necessary	  in	  two	  to	  five	  percent	  of	  cases.	  	  Diphtheria	  infection	  is	  spread	  from	  person	  to	  person	  and	  causes	  a	  thick	  covering	  to	  form	  in	  the	  back	  of	  the	  throat,	  which	  can	  lead	  to	  breathing	  problems	  and	  paralysis,	  heart	  failure,	  and	  death.	  	  Since	  the	  introduction	  of	  the	  diphtheria	  vaccine,	  cases	  have	  fallen	  by	  over	  99.9	  percent	  in	  the	  US	  from	  a	  yearly	  average	  of	  about	  175,000	  cases	  to	  almost	  no	  cases.	  	  Tetanus,	  or	  lockjaw,	  enters	  the	  body	  through	  open	  wounds	  and	  causes	  muscle	  spasms	  all	  over	  the	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body,	  and	  can	  lead	  to	  extreme	  tightening	  of	  jaw	  muscles.	  	  Tetanus	  is	  fatal	  in	  about	  20	  percent	  of	  cases;	  however,	  incidence	  in	  the	  US	  has	  fallen	  by	  over	  96	  percent	  since	  the	  introduction	  of	  the	  vaccine.	  	  The	  DTaP	  vaccine	  is	  given	  as	  series	  of	  four	  shots	  between	  the	  ages	  of	  two	  and	  eighteen	  months.	  	  A	  booster	  shot	  is	  recommended	  for	  children	  aged	  four	  to	  six	  years	  (CDC,	  2008c).	  	   The	  Healthy	  People	  2020	  objective	  for	  DTaP	  coverage	  is	  90	  percent	  immunization	  of	  four	  doses	  of	  the	  vaccine	  by	  age	  19	  to	  35	  months;	  the	  current	  baseline	  coverage	  is	  85	  percent	  (DHHS).	  	  As	  pertussis,	  especially,	  again	  becomes	  more	  and	  more	  common	  in	  the	  US,	  it	  is	  important	  to	  achieve	  immunization	  coverage	  goals	  for	  the	  DTaP	  vaccine.	  	  Due	  to	  declining	  pertussis	  immunization	  rates	  in	  the	  1970s	  and	  1980s,	  and	  the	  reduced	  efficacy	  of	  the	  vaccine	  over	  time,	  pertussis	  incidence	  has	  been	  increasing	  in	  the	  US	  since	  about	  1980	  (Gregory,	  2006).	  	  	  
 
Varicella	  
 Varicella,	  or	  chicken	  pox,	  is	  caused	  by	  the	  varicella	  virus	  and	  is	  characterized	  by	  rash,	  itching,	  and	  fever.	  	  Before	  the	  vaccine	  was	  introduced,	  varicella	  was	  a	  common	  and	  often	  mild	  childhood	  illness.	  	  However,	  severe	  illness	  can	  occur,	  especially	  in	  infants	  and	  adults,	  leading	  to	  severe	  skin	  infection,	  scarring,	  pneumonia,	  brain	  damage,	  and	  death;	  about	  100	  people	  in	  the	  US	  died	  from	  varicella	  infection	  annually	  before	  the	  vaccine	  was	  introduced.	  	  Infection	  with	  varicella	  also	  puts	  one	  at	  risk	  for	  shingles	  much	  later	  in	  life.	  	  The	  varicella	  vaccine	  is	  given	  as	  a	  series	  of	  two	  injections,	  one	  each	  at	  12	  to	  15	  months	  of	  age	  and	  four	  to	  six	  years	  of	  age.	  	  Additionally,	  any	  person	  who	  is	  not	  fully	  vaccinated	  and	  has	  never	  had	  the	  chicken	  pox	  should	  be	  immunized.	  	  The	  varicella	  vaccine	  can	  also	  be	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combined	  with	  the	  MMR	  vaccine	  in	  the	  measles-­‐mumps-­‐rubella-­‐varicella	  (MMRV)	  vaccine	  (CDC,	  2008b).	  	   In	  2008,	  91	  percent	  of	  children	  aged	  19	  to	  35	  months	  had	  received	  at	  least	  one	  dose	  of	  the	  varicella	  vaccine,	  surpassing	  the	  Healthy	  People	  2020	  goal	  of	  90	  percent	  immunization	  coverage	  (DHHS).	  	  	  
 
Others	  
 The	  influenza	  and	  meningococcal	  vaccines	  are	  also	  listed	  in	  Table	  1	  as	  recommended	  for	  children	  up	  to	  the	  age	  of	  the	  six	  years.	  	  Infection	  with	  the	  influenza	  virus	  causes	  fever,	  chills,	  muscle	  aches,	  fatigue,	  cough,	  and	  headache.	  	  There	  are	  two	  types	  of	  influenza	  vaccine:	  the	  inactivated	  vaccine,	  given	  in	  a	  shot,	  and	  the	  attenuated	  vaccine,	  given	  in	  a	  nasal	  spray.	  	  As	  different	  influenza	  viruses	  may	  be	  active	  every	  year,	  the	  flu	  shot	  changes	  every	  year	  and	  it	  is	  recommended	  that	  children	  over	  the	  age	  of	  six	  months	  receive	  a	  dose	  of	  either	  form	  of	  the	  vaccine	  yearly	  (CDC,	  2011e).	  	   The	  meningococcal	  vaccine	  protects	  against	  four	  types	  of	  meningococcal	  bacteria,	  which	  infect	  the	  fluid	  surrounding	  the	  brain	  and	  spinal	  cord.	  	  Bacterial	  meningitis	  is	  fatal	  in	  approximately	  ten	  percent	  of	  cases.	  	  The	  meningococcal	  vaccine	  is	  recommended	  for	  children	  aged	  two	  to	  six	  years	  who	  fall	  into	  a	  high-­‐risk	  category,	  such	  as	  those	  children	  without	  a	  spleen,	  or	  those	  traveling	  to	  areas	  in	  which	  bacterial	  meningitis	  is	  endemic	  (DHHS,	  2011;	  CDC,	  2011f).	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2.3	  Consequences	  of	  Unmet	  Goals	  
 Declining	  immunization	  rates	  lead	  to	  increased	  health	  care	  costs	  as	  well	  as	  increased	  morbidity	  and	  mortality.	  	  The	  United	  States	  has	  experienced	  recent	  outbreaks	  of	  vaccine-­‐preventable	  diseases	  including	  measles,	  pertussis,	  and	  mumps.	  	  In	  the	  case	  of	  pertussis,	  recent	  outbreaks	  have	  occurred	  in	  California,	  Michigan,	  and	  Ohio.	  	  Although	  immunization	  coverage	  seems	  to	  be	  relatively	  close	  to	  the	  target	  rate,	  pertussis	  can	  be	  difficult	  to	  diagnose	  and	  treat	  (Gregory,	  2006;	  CDC,	  2011d).	  	  Douglas	  notes	  that	  “pertussis	  is	  the	  only	  vaccine-­‐preventable	  disease	  associated	  with	  increasing	  deaths	  in	  the	  United	  States,	  climbing	  from	  4	  deaths	  in	  1996	  to	  17	  in	  2001,	  and	  occurring	  almost	  exclusively	  in	  infants	  younger	  than	  one	  year	  (Gregory,	  2006).”	  	  In	  2010,	  there	  were	  over	  27,500	  cases	  of	  pertussis	  in	  the	  US,	  with	  over	  9,000	  cases	  and	  ten	  infant	  deaths	  occurring	  in	  California.	  	  This	  was	  the	  worst	  outbreak	  of	  pertussis	  in	  California	  in	  over	  half	  a	  century.	  	  In	  adults,	  pertussis	  may	  be	  more	  difficult	  to	  recognize	  and	  diagnose,	  as	  coughs	  may	  not	  be	  accompanied	  by	  the	  “whooping”	  noise	  associated	  with	  the	  disease.	  	  As	  many	  as	  half	  of	  the	  cases	  seen	  in	  children	  were	  those	  in	  which	  the	  children	  were	  infected	  by	  their	  caregivers	  (CDC,	  2011d;	  Falco,	  2010).	  	  Therefore,	  as	  incidence	  of	  
Figure	  1.	  	  Reported	  pertussis	  incidence	  by	  age	  group,	  1990-­‐
2010	  (CDC,	  2011g)	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childhood	  pertussis	  increases,	  especially	  among	  infants	  [see	  figure	  1	  (CDC,	  2011g)],	  it	  is	  necessary	  to	  ensure	  that	  infants	  are	  properly	  immunized	  against	  pertussis	  by	  increasing	  coverage	  rates	  of	  the	  DTaP	  vaccine	  (CDC,	  2011g).	  	   The	  US	  has	  also	  seen	  a	  recent	  increase	  in	  measles	  cases,	  with	  118	  cases	  reported	  during	  the	  first	  six	  months	  of	  2011;	  the	  highest	  number	  since	  1996	  before	  endemic	  transmission	  was	  declared	  eliminated	  in	  the	  country.	  	  35	  percent	  of	  the	  cases	  were	  in	  children	  under	  five	  years	  old.	  	  40	  percent	  of	  the	  cases	  required	  hospitalization;	  all	  but	  one	  of	  the	  hospitalized	  cases	  were	  completely	  unvaccinated,	  and	  the	  last	  had	  received	  only	  one	  dose	  of	  measles	  vaccine	  (CDC,	  2011c).	  	  Approximately	  95	  percent	  immunization	  coverage	  is	  necessary	  to	  ensure	  herd	  immunity	  (Nagaraj,	  2006).	  	  However,	  in	  2008,	  only	  about	  92	  percent	  of	  children	  under	  the	  age	  of	  35	  months	  were	  appropriately	  vaccinated	  (DHHS);	  immunization	  rates	  have	  been	  considerably	  lower	  in	  other	  countries,	  leading	  to	  imported	  cases.	  	  Measles	  cases	  imported	  into	  the	  US	  can	  lead	  to	  many	  associated	  cases	  [see	  figure	  2	  (CDC,	  2008a)].	  	  These	  imported	  cases	  can	  also	  be	  extremely	  costly	  to	  the	  US;	  due	  to	  one	  imported	  case	  of	  measles	  in	  2008,	  two	  Arizona	  hospitals	  spent	  $799,136	  responding	  to	  the	  ensuing	  outbreak	  of	  14	  confirmed	  cases	  (Chen,	  et	  al.,	  2011).	  	  
Figure	  2.	  Trend	  in	  cases	  of	  imported	  measles	  as	  a	  
proportion	  of	  all	  measles	  cases,	  United	  States,	  1997-­‐
July	  2008	  (CDC,	  2008a)	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   Recent	  outbreaks	  of	  mumps	  have	  also	  occurred	  in	  the	  US.	  	  A	  2006	  outbreak	  involved	  more	  than	  2,500	  cases	  in	  eleven	  states,	  making	  it	  the	  largest	  outbreak	  in	  more	  than	  fifteen	  years.	  	  Most	  cases	  in	  this	  outbreak	  occurred	  in	  people	  aged	  18	  to	  24	  years;	  only	  about	  half	  of	  the	  cases	  had	  received	  the	  recommended	  two	  doses	  of	  mumps-­‐containing	  vaccine.	  	  A	  comparison	  of	  two	  college	  campuses	  in	  one	  Iowa	  county	  affected	  by	  the	  outbreak	  revealed	  a	  higher	  attack	  rate	  for	  students	  at	  the	  college	  with	  lower	  MMR	  immunization	  coverage	  (CDC,	  2006).	  	  In	  a	  more	  recent	  outbreak	  that	  began	  in	  2009,	  one	  case	  imported	  from	  the	  United	  Kingdom	  led	  to	  over	  1,500	  cases	  in	  New	  York	  and	  New	  Jersey.	  	  Over	  90	  percent	  of	  cases	  occurred	  in	  children	  under	  six	  years	  of	  age.	  	  About	  75	  percent	  of	  cases	  had	  received	  the	  recommended	  two	  doses	  of	  mumps-­‐containing	  vaccine;	  vaccination	  alone	  is	  not	  enough	  to	  prevent	  mumps	  from	  occurring	  in	  an	  individual,	  but	  very	  high	  immunization	  coverage	  can	  stop	  mumps	  transmission	  in	  a	  community	  and	  is	  the	  most	  effective	  way	  to	  prevent	  and	  control	  mumps	  outbreaks	  (CDC,	  2010c).	  	  As	  mumps	  can	  often	  cause	  relatively	  mild	  illness,	  mumps	  vaccination	  is	  not	  generally	  considered	  a	  very	  high	  priority	  when	  compared	  to	  other	  immunizations,	  but	  the	  complications	  of	  mumps	  infection	  can	  have	  long-­‐term	  consequences.	  For	  example,	  mumps	  orchitis	  is	  a	  risk	  factor	  for	  testicular	  cancer;	  more	  than	  one	  quarter	  of	  women	  in	  the	  first	  trimester	  of	  pregnancy	  who	  acquire	  mumps	  experience	  spontaneous	  abortion;	  mumps-­‐associated	  pancreatitis	  may	  trigger	  the	  development	  of	  insulin-­‐dependent	  diabetes	  mellitus	  in	  some	  affected	  individuals;	  and	  meningitis,	  the	  most	  common	  cause	  of	  mumps-­‐related	  hospitalizations,	  occurs	  in	  about	  ten	  percent	  of	  cases.	  	  These	  complications	  can	  lead	  to	  increased	  morbidity	  and	  higher	  health	  care	  costs	  for	  providers,	  insurers,	  and	  patients	  (Galazka,	  Robertson,	  &	  Kraigher,	  1999).	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2.4	  Immunization	  Barriers	  	   Immunization	  barriers	  prevent	  some	  people	  from	  being	  vaccinated	  or	  having	  their	  children	  vaccinated	  against	  infectious	  diseases.	  	  These	  barriers	  may	  affect	  either	  the	  patients	  or	  the	  providers	  of	  vaccines.	  	  Deutchman	  et	  al.	  in	  2000	  found,	  in	  a	  study	  of	  providers,	  that	  rural	  parental	  barriers	  to	  immunizations	  for	  their	  children	  included	  cost,	  parental	  attitudes	  regarding	  vaccines,	  language	  barriers,	  and	  transportation	  and	  mobility	  issues.	  	  Many	  of	  these	  barriers	  are	  common	  in	  urban	  settings	  as	  well;	  most	  barriers	  are	  common	  across	  different	  geographical	  regions	  and	  areas	  (Deutchman,	  Brayden,	  Siegel,	  Beaty,	  &	  Crane,	  2000).	  	  Cost	  of	  immunization	  and	  low	  socioeconomic	  status,	  especially,	  have	  long	  been	  known	  as	  common	  barriers	  to	  childhood	  immunization,	  for	  parents	  as	  well	  as	  providers,	  often	  preventing	  children	  living	  in	  poverty	  from	  receiving	  recommended	  immunizations	  (Zimmerman,	  et	  al.,	  2006;	  Smith,	  Stevenson,	  &	  Chu,	  2006;	  Thomas,	  Kohli,	  &	  King,	  2004).	  	  Systemic	  barriers	  to	  immunization,	  including	  transportation,	  are	  also	  commonly	  reported.	  	  Other	  parental	  barriers	  associated	  with	  incomplete	  childhood	  immunization	  include	  low	  maternal	  education,	  young	  maternal	  age,	  and	  large	  family	  size	  (Thomas,	  Kohli,	  &	  King,	  2004).	  	   Parental	  knowledge	  and	  attitudes	  regarding	  vaccines	  impact	  whether	  children	  receive	  recommended	  childhood	  immunizations	  (Stern	  &	  Markel,	  2005;	  Thomas,	  Kohli,	  &	  King,	  2004).	  	  Stern	  and	  Markel	  note	  that	  public	  reactions	  to	  vaccines	  have	  historically	  varied	  from	  amazement	  at	  the	  wonderful	  effects	  of	  vaccines	  to	  distrust	  and	  hostility	  and	  that	  “vaccines	  are	  powerful	  medical	  interventions	  that	  induce	  powerful	  biological,	  social,	  and	  cultural	  reactions	  (Stern	  &	  Markel,	  2005).”	  	  Other	  studies	  have	  concluded	  that	  the	  most	  important	  parental	  barrier	  to	  immunization	  is	  preconceived	  attitudes	  and	  beliefs	  about	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vaccines,	  and	  such	  beliefs	  can	  be	  a	  serious	  threat	  to	  the	  health	  of	  communities.	  	  Maternal	  education	  may	  contribute	  to	  attitudes	  as	  well;	  as	  better-­‐educated	  parents	  may	  be	  more	  aware	  of	  the	  dangers	  of	  not	  immunizing	  and	  are	  more	  likely	  to	  follow	  immunization	  guidelines	  (Thomas,	  Kohli,	  &	  King,	  2004).	  	  Additionally,	  vaccines	  may	  be	  victims	  of	  their	  own	  success;	  they	  have	  worked	  so	  well	  to	  prevent	  infectious	  disease,	  especially	  in	  developed	  countries,	  that	  the	  public	  no	  longer	  remembers	  the	  severity	  of	  many	  once-­‐common	  diseases	  (Stern	  &	  Markel,	  2005).	  	  One	  1997	  study	  reported	  that	  “in	  general,	  parents	  exhibited	  no	  understanding	  of	  the	  nature	  of	  the	  diseases	  immunizations	  protect	  against	  (McCormick,	  Bartholomew,	  Lewis,	  Brown,	  &	  Hanson,	  1997).”	  	   Parental	  attitudes	  regarding	  immunization	  are	  often	  affected	  by	  the	  media	  and	  sensational	  stories	  related	  to	  potential	  side-­‐effects	  of	  vaccines	  (McCormick,	  Bartholomew,	  Lewis,	  Brown,	  &	  Hanson,	  1997).	  	  Recent	  controversies	  over	  the	  safety	  of	  the	  MMR	  vaccine,	  for	  example,	  have	  led	  immunization	  coverage	  rates	  to	  falter	  in	  parts	  of	  the	  developed	  world	  (CDC,	  2008a).	  	  A	  paper	  by	  Wakefield	  et	  al.,	  later	  discovered	  to	  be	  fraudulent	  and	  based	  on	  unethical	  research,	  lead	  measles	  vaccination	  rates	  to	  fall	  from	  over	  90	  percent	  to	  about	  70	  percent	  in	  the	  United	  Kingdom	  with	  rates	  as	  low	  as	  50	  percent	  in	  some	  communities.	  	  The	  percentage	  of	  parents	  choosing	  not	  to	  have	  their	  children	  immunized	  rises	  along	  with	  the	  media	  output	  of	  similar	  sensationalist	  stories,	  regardless	  of	  their	  scientific	  basis	  (Smith,	  Ellenberg,	  Bell,	  &	  Rubin,	  2008).	  	  	  Provider	  barriers	  to	  immunization	  include	  poor	  record	  keeping,	  low	  reimbursement	  rates,	  vaccine	  storage	  issues,	  and	  failure	  to	  counsel	  parents	  and	  to	  immunize	  children	  at	  sick	  visits.	  	  Very	  few	  physicians	  report	  that	  immunization	  reimbursement	  rates	  are	  adequate,	  especially	  for	  those	  children	  with	  Medicaid	  (Zimmerman,	  et	  al.,	  2006).	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Nonexistent	  or	  inaccessible	  immunization	  records	  can	  prevent	  parents	  from	  accessing	  immunization	  and	  providers	  from	  giving	  vaccines	  to	  children.	  	  Multiple	  relocations	  during	  a	  child’s	  life	  are	  associated	  with	  incomplete	  immunization	  among	  immigrant	  children,	  suggesting	  that	  records	  are	  not	  being	  appropriately	  transferred	  from	  old	  to	  new	  providers.	  	  Additionally,	  providers	  should	  be	  immunizing	  children	  whenever	  possible	  and	  appropriate,	  such	  as	  during	  sick	  visits.	  	  Record	  keeping	  is	  further	  confused	  when	  patients	  are	  referred	  to	  alternate	  care	  locations	  for	  immunizations.	  	  Generally,	  immunizations	  are	  scheduled	  for	  well-­‐child	  visits,	  but	  economic	  and	  transportation	  barriers	  may	  lead	  parents	  to	  skip	  physician	  appointments	  when	  their	  child	  is	  well	  (Deutchman,	  Brayden,	  Siegel,	  Beaty,	  &	  Crane,	  2000).	  	  Parents	  have	  reported	  that	  sick-­‐child	  care	  is	  more	  accessible	  and	  available	  than	  well-­‐child	  care	  (McCormick,	  Bartholomew,	  Lewis,	  Brown,	  &	  Hanson,	  1997).	  	  Therefore,	  “once	  these	  children	  are	  ‘in	  the	  door’,	  proper	  employment	  of	  the	  immunization	  practice	  standards	  should	  help	  improve	  immunization	  rates	  (Deutchman,	  Brayden,	  Siegel,	  Beaty,	  &	  Crane,	  2000).”	  	  Research	  has	  also	  shown	  that	  while	  providers	  are	  generally	  knowledgeable	  about	  the	  safety	  and	  importance	  of	  immunizations,	  increased	  provider	  education	  would	  positively	  impact	  immunization	  uptake	  among	  children.	  	  Also,	  even	  when	  providers	  are	  very	  well-­‐informed,	  this	  knowledge	  sometimes	  fails	  to	  translate	  into	  the	  clinical	  setting	  and	  does	  not	  necessarily	  result	  in	  higher	  immunization	  rates	  (Thomas,	  Kohli,	  &	  King,	  2004).	  Many	  providers	  may	  refer	  at	  least	  some	  patients	  to	  alternate	  sources	  of	  care	  –	  generally,	  public	  health	  departments	  or	  clinics	  –	  for	  immunizations,	  which	  can	  lead	  to	  these	  patients	  forgoing	  vaccines	  due	  to	  economic,	  scheduling,	  and	  transportation	  difficulties.	  	  Reasons	  given	  by	  providers	  for	  immunization	  referrals	  include	  low	  reimbursement	  rates,	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paperwork,	  difficulty	  obtaining	  vaccines,	  and	  ineligibility	  for	  or	  non-­‐participation	  in	  the	  VFC	  program.	  	  Many	  providers	  report	  feeling	  that	  vaccine	  reimbursement	  from	  both	  public	  and	  private	  sources	  is	  inadequate	  (Zimmerman,	  et	  al.,	  2006;	  Deutchman,	  Brayden,	  Siegel,	  Beaty,	  &	  Crane,	  2000).	  	  	  Research	  has	  concluded	  that,	  in	  some	  instances,	  VFC	  and	  SCHIP	  have	  impacted	  the	  tendency	  of	  physicians	  to	  refer	  uninsured	  and	  underinsured	  children	  to	  alternate	  providers	  for	  immunizations;	  however,	  such	  referrals	  continue	  to	  occur,	  especially	  among	  providers	  who	  do	  not	  participate	  in	  the	  VFC	  program	  (Zimmerman,	  et	  al.,	  2006).	  	  Also,	  referring	  patients	  to	  a	  public	  health	  care	  setting	  for	  immunizations	  may	  create	  an	  additional	  barrier,	  as	  parents	  whose	  children	  receive	  vaccines	  in	  clinic	  settings	  report	  having	  to	  take	  much	  more	  responsibility	  for	  their	  children’s	  immunizations	  than	  parents	  whose	  children	  receive	  immunizations	  from	  private	  providers;	  these	  parents	  are	  more	  likely	  to	  rely	  on	  their	  provider	  to	  initiate	  vaccinations	  and	  to	  inform	  them	  of	  the	  recommended	  schedule	  (McCormick,	  Bartholomew,	  Lewis,	  Brown,	  &	  Hanson,	  1997).	  	  The	  fragmentation	  of	  care	  creates	  an	  additional	  burden	  on	  the	  parents	  to	  have	  their	  children	  immunized,	  and	  coverage	  rates	  drop	  when	  children	  do	  not	  receive	  immunizations	  at	  their	  primary	  medical	  home	  (Zimmerman,	  et	  al.,	  2006).	  
 
2.5	  Insurance	  and	  Immunizations	  Researchers	  have	  studied	  the	  relationship	  between	  insurance	  type	  and	  immunization	  uptake,	  most	  recently	  to	  determine	  the	  impact	  of	  programs	  such	  as	  SCHIP	  and	  VFC	  on	  immunization	  rates.	  	  Often,	  access	  to	  vaccines	  is	  affected	  when	  patients	  are	  referred	  from	  one	  provider	  to	  another	  for	  vaccines.	  	  Referrals	  seem	  to	  have	  decreased	  over	  time	  following	  the	  introduction	  of	  the	  VFC	  program,	  but	  physicians	  were	  still	  likely	  to	  refer	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certain	  children.	  	  In	  a	  study	  of	  primary	  care	  physicians	  in	  Minnesota	  and	  Pennsylvania,	  Zimmerman	  et	  al.	  found	  that	  likelihood	  of	  referrals	  ranged	  from	  three	  percent	  for	  children	  with	  insurance	  that	  pays	  for	  immunization	  to	  60	  percent	  for	  children	  without	  insurance	  whose	  parents	  were	  unable	  to	  pay	  for	  vaccines	  (Zimmerman,	  et	  al.,	  2006).	  	  However,	  Deutchman	  et	  al.	  pointed	  out	  that	  “many	  patients	  referred	  out	  are	  those	  who	  are	  uninsured	  or	  whose	  medical	  care	  is	  publicly	  funded.	  	  In	  reality,	  there	  is	  no	  need	  for	  these	  referrals	  …	  because	  public	  programs	  do	  reimburse	  providers	  for	  immunizations,	  and	  the	  federal	  Vaccines	  for	  Children	  (VFC)	  program	  provides	  free	  vaccines	  for	  uninsured	  and	  underinsured	  children	  to	  providers	  who	  participate	  in	  the	  program	  (Deutchman,	  Brayden,	  Siegel,	  Beaty,	  &	  Crane,	  2000).”	  	  Indeed,	  physicians	  not	  participating	  in	  the	  VFC	  program	  were	  likely	  to	  refer	  children	  with	  Medicaid	  to	  alternate	  care	  centers	  for	  immunizations	  55	  percent	  of	  the	  time,	  while	  participating	  physicians	  only	  referred	  six	  percent	  of	  Medicaid	  children	  (Zimmerman,	  et	  al.,	  2006).	  Likewise,	  research	  studies	  indicate	  that	  insurance	  type	  and	  status	  are	  often	  associated	  with	  immunization	  rates,	  despite	  the	  programs	  in	  place	  to	  prevent	  these	  disparities	  (Zimmerman,	  et	  al.,	  2006;	  Blewett,	  Davidson,	  Bramlett,	  Rodin,	  &	  Messonnier,	  2008).	  	  This	  has	  an	  important	  impact	  on	  children	  in	  the	  US,	  as	  almost	  ten	  percent	  of	  those	  under	  18	  years	  of	  age,	  or	  7.3	  million	  American	  children,	  were	  uninsured	  in	  2008	  (U.S.	  Census	  Bureau,	  2010).	  	  Smith,	  Johnson,	  and	  Chu	  analyzed	  National	  Immunization	  Survey	  data	  from	  2001	  and	  2002	  and	  found	  that	  about	  13	  percent	  of	  children	  were	  reportedly	  uninsured	  at	  some	  time,	  and	  that	  children	  without	  insurance	  were	  less	  likely	  to	  be	  fully	  immunized	  than	  those	  with	  insurance.	  	  In	  fact,	  children	  with	  any	  break	  in	  insurance	  coverage	  were	  significantly	  less	  likely	  to	  be	  fully	  immunized	  than	  those	  who	  had	  been	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continuously	  ensured	  for	  their	  lifetime,	  regardless	  of	  whether	  they	  were	  covered	  by	  public	  or	  private	  insurance,	  a	  relationship	  which	  has	  been	  addressed	  and	  confirmed	  by	  multiple	  studies	  (Smith,	  Stevenson,	  &	  Chu,	  2006;	  Blewett,	  Davidson,	  Bramlett,	  Rodin,	  &	  Messonnier,	  2008).	  	  However,	  those	  covered	  by	  public	  insurance	  were	  more	  likely	  to	  have	  experienced	  a	  break	  in	  insurance	  coverage	  in	  their	  lifetime.	  	  Despite	  the	  differences	  between	  different	  types	  of	  insurance,	  no	  significant	  differences	  were	  found	  between	  those	  with	  public	  and	  private	  insurance	  as	  long	  as	  coverage	  was	  continuous	  and	  after	  researchers	  controlled	  for	  important	  sociodemographic	  factors	  including	  race,	  ethnicity,	  income,	  mother’s	  age,	  marital	  status,	  and	  education	  (Smith,	  Stevenson,	  &	  Chu,	  2006).	  A	  previous	  study	  of	  children	  aged	  19	  to	  35	  months	  reached	  similar	  conclusions,	  with	  the	  exception	  that	  the	  differences	  in	  immunization	  coverage	  between	  publicly	  and	  privately	  insured	  children	  remained	  significant.	  	  In	  predictive	  models	  for	  insurance	  type	  or	  insurance	  status	  combined	  with	  other	  sociodemographic	  variables,	  those	  related	  to	  immunization	  completeness	  included	  race/ethnicity,	  poverty	  status,	  and	  urban	  residence.	  	  However,	  in	  each	  model,	  insurance	  type	  and	  insurance	  status	  remained	  the	  most	  important	  predictors	  of	  complete	  immunization	  (Zhao,	  Mokdad,	  &	  Barker,	  2004).	  	  Although	  the	  more	  recent	  studies	  show	  a	  less	  significant	  impact	  of	  insurance	  type	  as	  long	  as	  children	  were	  insured	  in	  some	  way,	  there	  is	  so	  far	  insufficient	  research	  to	  determine	  whether	  the	  impact	  of	  the	  VFC	  and	  SCHIP	  programs	  have	  improved	  immunization	  coverage	  rates	  among	  children	  in	  the	  US.	  	  One	  study	  published	  in	  2005	  concluded	  that	  while	  immunization	  rates	  have	  increased	  for	  all	  income	  groups	  since	  1995,	  the	  increases	  were	  similar	  across	  income	  groups,	  suggesting	  that	  the	  SCHIP	  program	  had	  little	  impact	  on	  the	  increase	  in	  immunization	  coverage	  (Joyce	  &	  Racine,	  2005).	  	  However,	  research	  is	  beginning	  to	  indicate	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a	  closing	  gap	  between	  public	  and	  private	  insurance	  with	  relation	  to	  childhood	  immunization	  coverage	  when	  other	  sociodemographic	  factors	  are	  taken	  into	  consideration,	  and	  that	  the	  most	  vulnerable	  segment	  of	  the	  population	  might	  now	  be	  shifting	  towards	  those	  who	  are	  intermittently	  covered	  with	  private	  insurance,	  as	  they	  may	  not	  be	  accessing	  public	  insurance	  or	  programs	  that	  provide	  vaccines	  during	  the	  times	  when	  they	  are	  uninsured	  (Blewett,	  Davidson,	  Bramlett,	  Rodin,	  &	  Messonnier,	  2008).	  Despite	  the	  availability	  of	  public	  programs	  meant	  to	  ensure	  universal	  access	  to	  childhood	  vaccines,	  reports	  continue	  to	  show	  that	  children	  in	  poverty	  are	  more	  likely	  to	  be	  uninsured	  (U.S.	  Census	  Bureau,	  2010)	  and	  less	  likely	  to	  be	  appropriately	  immunized	  (Zimmerman,	  et	  al.,	  2006;	  Smith,	  Stevenson,	  &	  Chu,	  2006).	  	  However,	  more	  recent	  studies	  indicate	  that	  a	  growing	  factor	  in	  whether	  children	  receive	  the	  recommended	  immunizations	  might	  be	  the	  continuity	  of	  insurance	  coverage,	  regardless	  of	  whether	  the	  insurance	  coverage	  is	  public	  or	  private	  (Blewett,	  Davidson,	  Bramlett,	  Rodin,	  &	  Messonnier,	  2008).	  	  This	  study	  investigates	  the	  relationship	  between	  childhood	  immunizations	  and	  insurance	  status,	  including	  whether	  a	  child	  is	  covered	  by	  public	  or	  private	  insurance,	  whether	  a	  child	  is	  eligible	  to	  receive	  free	  vaccines	  through	  the	  Vaccines	  for	  Children	  program,	  and	  whether	  insurance	  coverage	  is	  continuous	  over	  time.	  	  	  




3.1	  Source	  of	  Data	  	   The	  data	  analyzed	  was	  taken	  from	  the	  2010	  National	  Immunization	  Survey	  (NIS),	  which	  is	  a	  survey	  conducted	  by	  the	  National	  Center	  for	  Immunizations	  and	  Respiratory	  Diseases	  (NCIRD)	  and	  the	  National	  Center	  for	  Health	  Statistics	  (NCHS)	  of	  the	  CDC.	  	  In	  1992,	  the	  Childhood	  Immunization	  Initiative	  (CII)	  was	  established	  to	  address	  vaccine	  coverage	  concerns	  in	  the	  US.	  	  Healthy	  People	  2000,	  2010,	  and	  2020	  established	  related	  immunization	  coverage	  goals.	  	  The	  NIS	  was	  created	  and	  implemented	  in	  order	  to	  fulfill	  the	  CII	  mandate	  of	  monitoring	  vaccine	  coverage	  and	  evaluating	  progress	  toward	  the	  CII	  and	  Healthy	  People	  goals	  (NIS,	  2011).	  The	  first	  part	  of	  the	  NIS	  is	  a	  nation-­‐wide,	  list-­‐assisted	  random-­‐digit	  dialing	  household	  telephone	  survey.	  	  For	  households	  containing	  children	  in	  the	  target	  age	  range,	  interviewers	  collect	  information	  from	  the	  most	  knowledgeable	  adult	  about	  the	  child’s	  immunization	  history.	  	  The	  second	  part	  of	  the	  survey	  is	  a	  brief	  written	  questionnaire	  designed	  to	  collect	  information	  from	  the	  child’s	  medical	  records,	  which	  is	  mailed	  to	  each	  child’s	  immunization	  providers	  upon	  the	  consent	  of	  the	  parent	  or	  guardian	  of	  the	  child.	  	  NIS	  data	  on	  children	  in	  the	  US	  between	  the	  ages	  of	  19	  and	  35	  months	  has	  been	  collected	  since	  1994,	  and	  measures	  immunization	  coverage	  relative	  to	  rates	  recommended	  by	  the	  Advisory	  Committee	  on	  Immunization	  Practices	  (ACIP).	  	  Immunization	  coverage	  estimates	  are	  produced	  for	  the	  country	  as	  a	  whole,	  for	  each	  state,	  and	  for	  selected	  urban	  areas.	  	  Estimates	  are	  used	  to	  evaluate	  progress	  toward	  national	  immunization	  goals	  and	  to	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determine	  which	  states	  have	  the	  highest	  and	  lowest	  immunization	  coverage	  rates.	  	  The	  target	  study	  population	  of	  the	  NIS	  includes	  all	  children	  aged	  19	  to	  35	  months	  living	  in	  the	  US	  at	  the	  time	  of	  the	  interview	  (NIS,	  2011).	  	  Children	  aged	  19	  to	  35	  months	  are	  considered	  officially	  up-­‐to-­‐date	  (UTD)	  on	  immunizations	  if	  they	  have	  received	  all	  of	  the	  recommended	  vaccines	  [see	  table	  2	  (NIS,	  2011)].	  	  Coverage	  of	  certain	  series	  of	  vaccines	  is	  also	  measured,	  including	  the	  4:3:1:3:3:1,	  which	  lists	  the	  number	  of	  doses	  each	  of	  DTaP,	  polio,	  MMR,	  Hib,	  hepatitis	  B,	  and	  varicella	  vaccines;	  and	  the	  4:3:1:3:3:1:4,	  which	  adds	  4	  doses	  of	  the	  PCV	  vaccine	  to	  the	  previous	  series.	  	  The	  2010	  NIS	  household	  interviews	  were	  conducted	  between	  January	  7,	  2010	  and	  February	  7,	  2011.	  	  Provider	  data	  was	  collected	  between	  January	  2010	  and	  May	  2011.	  	  In	  the	  households	  surveyed,	  there	  were	  a	  total	  of	  24,013	  children	  within	  the	  appropriate	  age	  range.	  	  Of	  these,	  17,004	  (70.81%)	  had	  adequate	  provider	  data	  to	  determine	  whether	  the	  child	  was	  up-­‐to-­‐date	  with	  immunizations;	  more	  extensive	  data	  is	  available	  for	  these	  children	  (NIS,	  2011).	  
Table	  2.	  Number	  of	  doses	  per	  vaccine	  recommended	  by	  the	  CDC	  for	  Children	  by	  age	  2	  years	  Vaccine	   Number	  of	  Doses	  DTaP	  	  (also	  TDaP,	  DTP,	  or	  DT)	   4	  Polio	   3	  MMR	   1	  Hib	   3	  or	  4*	  Hepatitis	  B	   3	  Varicella	   1	  PCV	   4	  Hepatitis	  A	   2	  Influenza	   yearly	  Rotavirus	   2	  or	  3*	  *	  Number	  of	  doses	  depends	  on	  brand	  of	  vaccine	  used	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Figure	  3.	  Question	  flow	  for	  the	  eight	  insurance	  variables	  included	  
in	  the	  public	  use	  file	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available	  [see	  figure	  3	  for	  the	  insurance-­‐related	  question	  flow	  (DHHS	  &	  NCHS,	  2011)].	  	  Insurance	  measures	  in	  the	  data	  set	  included	  whether	  or	  not	  the	  child	  had	  insurance	  from	  an	  employer	  or	  union,	  whether	  or	  not	  the	  child	  was	  covered	  by	  Medicaid	  or	  SCHIP,	  whether	  or	  not	  the	  child	  was	  covered	  by	  Indian	  Health	  Services,	  Military	  Health	  Care,	  TRICARE,	  CHAMPUS,	  or	  CHAMP-­‐VA,	  or	  whether	  the	  child	  had	  been	  covered	  by	  health	  insurance	  through	  any	  other	  means.	  	  Additionally,	  the	  data	  set	  contained	  a	  variable	  regarding	  whether	  the	  child	  had	  ever	  experienced	  any	  gaps	  in	  insurance	  coverage	  or	  was	  covered	  continuously	  throughout	  his	  or	  her	  lifetime.	  	  The	  first	  insurance-­‐related	  variable	  created	  was	  whether	  each	  child	  was	  covered	  by	  any	  health	  insurance	  at	  any	  point.	  	  Next,	  the	  variables	  regarding	  insurance	  type	  were	  recoded	  into	  a	  single	  binary	  variable:	  public	  health	  insurance	  only	  (classifying	  public	  insurance	  according	  to	  the	  2010	  National	  Immunization	  Survey,	  the	  child	  was	  covered	  under	  Medicaid,	  SCHIP,	  Indian	  Health	  Services,	  Military	  Health	  Care,	  TRICARE,	  CHAMPUS,	  or	  CHAMP-­‐VA),	  or	  private	  health	  insurance	  (the	  child	  was	  covered	  at	  any	  time	  by	  health	  insurance	  through	  an	  employer,	  a	  union,	  or	  from	  another	  source).	  	  Next,	  reported	  gaps	  in	  insurance	  coverage	  were	  recoded	  into	  a	  binary	  variable	  regarding	  whether	  health	  insurance	  coverage	  had	  been	  continuous	  throughout	  the	  child’s	  lifetime.	  	   The	  primary	  dependent	  variables	  studied	  were	  measures	  of	  up-­‐to-­‐date	  immunization	  status.	  Up-­‐to-­‐date	  immunization	  status	  was	  used	  to	  measure	  immunization	  uptake,	  as	  a	  means	  of	  addressing	  the	  overall	  immunization	  situation	  for	  each	  child	  rather	  than	  looking	  at	  each	  individual	  vaccine.	  	  	  As	  there	  is	  no	  universally-­‐used	  definition	  of	  up-­‐to-­‐date	  immunization	  status,	  three	  separate	  definitions	  were	  used	  (see	  table	  3).	  	  The	  4:3:1:3:3:1	  vaccine	  series	  is	  the	  most	  commonly	  used	  definition	  of	  up-­‐to-­‐date	  for	  childhood	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immunizations,	  so	  provider-­‐reported	  status	  for	  the	  4:3:1:3:3:1	  series,	  a	  composite	  variable	  created	  by	  the	  publishers	  of	  the	  data,	  was	  the	  first	  variable	  used	  to	  define	  up-­‐to-­‐date.	  	  This	  series	  includes	  the	  DTaP,	  polio,	  MMR,	  Hib,	  hepatitis	  B,	  and	  varicella	  vaccines.	  	  The	  second	  definition	  of	  up-­‐to-­‐date	  insurance	  status	  was	  based	  on	  the	  requirements	  for	  entry	  into	  the	  Georgia	  public	  school	  system,	  adjusted	  for	  age-­‐appropriateness	  to	  fit	  the	  study	  population.	  	  This	  composite	  variable	  includes	  the	  DTaP,	  Hepatitis	  A,	  polio,	  MMR,	  varicella,	  and	  hepatitis	  B	  vaccines.	  	  This	  variable	  is	  meant	  to	  be	  used	  as	  a	  proxy	  for	  general	  immunization	  requirements	  for	  entry	  into	  public	  schools,	  although	  mandates	  vary	  from	  state	  to	  state.	  	  The	  final	  definition	  of	  up-­‐to-­‐date	  immunization	  status	  is	  a	  composite	  variable,	  which	  includes	  all	  vaccines	  recommended	  by	  the	  CDC	  for	  all	  children	  in	  the	  study	  population	  except	  the	  influenza	  vaccine.	  	  
Table	  3.	  Vaccines	  included	  in	  definitions	  of	  up-­‐to-­‐date	  immunization	  status	  Up-­‐To-­‐Date	  Status	  Definitions	  	   	   	   	   	  
	  
4:3:1:3:3:1	  	  	  Series	   GA	  School	  Requirements*	   CDC	  	  Recommend-­‐ations	  
Vaccin
e	  (#	  of	  
doses)
	   DTaP	  (4+)	   x	   x	   x	  Hepatitis	  A	  (2+)	   	  	   x	   x	  Hepatitis	  B	  (3+)	   x	   x	   x	  Hib	  (3+)	   	  	   	  	   x	  MMR	  (1+)	   x	   x	   x	  Rotavirus	  (3+)	   x	   	  	   x	  PCV	  (4+)	   	   	   x	  Polio	  (3+)	   x	   x	   x	  Varicella	  (1+)	   x	   x	   x	  
	   *Age-­‐adjusted	  to	  fit	  study	  population	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Table	  4.	  	  Crosstab	  analyses	  performed	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   Logistic	  regression	  was	  also	  performed	  to	  investigate	  the	  impact	  of	  selected	  variables	  on	  up-­‐to-­‐date	  status.	  	  Variables	  were	  selected	  based	  on	  the	  literature;	  the	  goal	  was	  not	  to	  find	  the	  best	  model	  for	  predicting	  up-­‐to-­‐date	  status,	  but	  simply	  to	  further	  explore	  relationships	  among	  variables	  generally	  considered	  to	  be	  important	  predictors	  of	  up-­‐to-­‐date	  status.	  	  Independent	  variables	  included	  those	  for	  child’s	  race/ethnicity,	  mother’s	  education,	  mother’s	  marital	  status,	  household	  poverty	  status,	  insurance	  type,	  insurance	  continuity,	  and	  number	  of	  providers.	  	  The	  variable	  for	  child’s	  age	  range	  was	  included	  as	  well,	  though	  not	  specifically	  listed	  in	  the	  literature,	  because	  it	  might	  impact	  whether	  children	  are	  up-­‐to-­‐date	  at	  the	  time	  of	  the	  survey.	  	  Logistic	  regression	  was	  performed	  for	  the	  US	  and	  for	  Georgia,	  using	  each	  of	  the	  three	  definitions	  of	  up-­‐to-­‐date	  immunization	  status	  as	  the	  dependent	  variable.	  	  




4.1	  Descriptive	  Statistics	  	   Frequencies	  were	  calculated	  for	  sociodemographic	  variables	  in	  order	  to	  describe	  the	  study	  population.	  	  The	  national	  (n=24013)	  and	  state	  of	  Georgia	  (n=420)	  survey	  populations	  were	  similar	  with	  respect	  to	  most	  variables	  (see	  table	  5).	  	  	  Survey	  participants	  	  
Table	  5.	  Descriptive	  variables	  for	  survey	  populations	  
	  	   United	  States	   Georgia	  Frequency	   Percent	   Frequency	   Percent	  CHILD’S	  AGE	  CATEGORY	   	  	   	  	   	  	   	  	  19-­‐23	  months	   6813	   28.37	   118	   28.1	  24-­‐29	  months	   8493	   35.37	   166	   39.52	  30-­‐35	  months	   8707	   36.26	   136	   32.38	  CHILD’S	  SEX	   	  	   	  	   	  	   	  	  Male	   12220	   50.89	   209	   49.76	  Female	   11793	   49.11	   211	   50.27	  CHILD’S	  RACE/ETHNICITY	   	  	   	  	   	  	   	  	  Hispanic	   4170	   17.37	   46	   10.95	  Non-­‐Hispanic	  White	  Only	   14612	   60.85	   225	   53.57	  Non-­‐Hispanic	  Black	  Only	   2685	   11.18	   116	   27.62	  Non-­‐Hispanic	  Other	  +	  Multiple	  Race	   2546	   10.6	   33	   7.86	  MOTHER’S	  EDUCATION	   	  	   	  	   	  	   	  	  <	  12	  Years	   2507	   10.44	   49	   11.67	  12	  Years	   4341	   18.08	   65	   15.48	  >	  12	  Years,	  Non-­‐College	  Grad	   6154	   25.63	   117	   27.86	  College	  Grad	   11011	   45.85	   189	   45	  MOTHER’S	  AGE	  CATEGORY	   	  	   	  	   	  	   	  	  <=	  19	  Years	   422	   1.76	   13	   3.1	  20-­‐29	  Years	   7682	   31.99	   137	   32.62	  >=	  30	  Years	   15909	   66.25	   270	   64.29	  MOTHER’S	  MARITAL	  STATUS	   	  	   	  	   	  	   	  	  Married	   17938	   74.7	   306	   72.86	  Unmarried	   6075	   25.3	   114	   27.14	  HOUSEHOLD	  POVERTY	  STATUS	   	  	   	  	   	  	   	  	  Above	  Poverty,	  >	  $75K	   8658	   36.06	   145	   34.52	  Above	  Poverty,	  <=	  $75K	   9023	   37.58	   146	   34.76	  Below	  Poverty	   5002	   20.83	   100	   23.81	  Unknown	   1330	   5.54	   29	   6.9	  CHILD	  HAS	  RECEIVED	  WIC	  BENEFITS	   	  	   	  	   	  	   	  	  Yes	   9869	   41.1	   189	   45	  No	   14022	   58.39	   231	   55	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from	  Georgia	  were	  more	  likely	  to	  be	  Non-­‐Hispanic	  Black	  Only	  (27%)	  than	  national	  respondents	  (11%),	  and	  mothers	  were	  more	  likely	  to	  be	  less	  than	  19	  years	  old	  (3.1%	  in	  GA;	  1.7%	  in	  the	  US).	  	  Georgia	  households	  surveyed	  were	  more	  likely	  to	  fall	  below	  the	  poverty	  line	  (24%)	  and	  to	  have	  received	  WIC	  benefits	  (45%)	  than	  national	  participants	  (21%	  and	  41%,	  respectively).	  	  Frequencies	  were	  also	  determined	  for	  variables	  related	  to	  insurance	  and	  provider	  variables	  (see	  table	  6)	  as	  well	  as	  for	  immunization	  status	  (see	  table	  7)	  for	  the	  US	  and	  for	  Georgia.	  	  
Insurance	  and	  Provider	  Information	  	   All	  children	  in	  the	  survey	  population	  had	  been	  covered	  by	  health	  insurance	  at	  some	  point	  in	  their	  lifetimes.	  	  Both	  nationally	  and	  in	  Georgia,	  most	  children	  were	  covered	  under	  insurance	  provided	  through	  their	  parents’	  employer	  or	  union	  (US	  n=11840,	  GA	  n=202).	  	  Approximately	  30	  percent	  of	  those	  surveyed	  nationally	  and	  in	  Georgia	  had	  only	  been	  covered	  by	  public	  insurance	  throughout	  their	  lifetime;	  however,	  a	  greater	  percentage	  of	  respondents	  (US	  37%,	  GA	  38%)	  were	  eligible	  for	  the	  Vaccines	  for	  Children	  Program.	  	  Over	  90	  percent	  of	  children	  had	  been	  covered	  by	  insurance	  continuously	  throughout	  their	  lifetimes.	  	  About	  70	  percent	  of	  respondents	  had	  adequate	  provider	  data	  to	  determine	  up-­‐to-­‐date	  status	  for	  vaccines	  and	  vaccine	  series.	  	  For	  children	  with	  no	  providers	  responding	  to	  the	  written	  questionnaire	  (US	  29%,	  GA	  27%),	  data	  were	  inadequate	  for	  determining	  up-­‐to-­‐date	  immunization	  status.	  	  For	  over	  half	  of	  the	  children	  in	  the	  study	  population,	  only	  one	  provider	  responded	  with	  immunization	  information;	  few	  children	  had	  two	  (US	  14%,	  GA	  11%)	  or	  three	  or	  more	  (US	  2%,	  GA	  3%)	  vaccine	  providers.	  	  Over	  90	  percent	  of	  children	  in	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the	  national	  sample	  received	  vaccines	  from	  providers	  participating	  in	  the	  VFC	  program,	  while	  just	  under	  85	  percent	  of	  those	  in	  the	  Georgia	  sample	  saw	  participating	  providers.	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Immunization	  Information	  	   Immunization	  rates	  seemed	  overall	  to	  be	  higher	  statewide	  in	  Georgia	  than	  nationally	  (see	  table	  7).	  	  For	  individual	  vaccines,	  the	  largest	  disparity	  was	  with	  the	  hepatitis	  A	  vaccine;	  65	  percent	  of	  Georgian	  respondents	  had	  received	  the	  appropriate	  number	  of	  vaccine	  doses,	  while	  only	  49	  percent	  of	  national	  respondents	  were	  up-­‐to-­‐date.	  	  The	  only	  vaccine	  for	  which	  Georgia	  was	  below	  the	  national	  percentage	  was	  the	  Hib	  vaccine;	  89	  percent	  of	  respondents	  from	  Georgia	  and	  90	  percent	  of	  respondents	  nationally	  were	  up-­‐to-­‐date	  for	  that	  vaccine.	  	  Coverage	  rates	  were	  about	  90	  percent	  or	  higher	  for	  the	  hepatitis	  B,	  Hib,	  MMR,	  polio,	  and	  varicella	  vaccines.	  	  The	  lowest	  up-­‐to-­‐date	  immunization	  status	  rates	  were	  for	  the	  hepatitis	  A	  (48%	  nationally,	  65%	  in	  Georgia)	  and	  rotavirus	  (US	  61%,	  GA	  67%)	  vaccines.	  	  
Table	  7.	  Immunization	  variables	  
	  	   United	  States	   Georgia	  UTD	   Not	  UTD	   %	  UTD	   UTD	   Not	  UTD	   %	  UTD	  Individual	  Immunizations	   	  	   	  	   	  	   	  	   	  	   	  	  DTaP	  (4+	  doses)	   14509	   2610	   84.75	   267	   40	   86.97	  Hepatitis	  A	  (2+	  doses)	   8375	   8744	   48.92	   199	   108	   64.82	  Hepatitis	  B	  (3+	  doses)	   15580	   1539	   91.01	   293	   14	   95.44	  Hib	  (3+	  doses)	   15420	   1699	   90.08	   274	   33	   89.25	  MMR	  (1+	  doses)	   15534	   1585	   90.74	   281	   26	   91.53	  Rotavirus	  (3+	  doses)	   10412	   6707	   60.82	   205	   102	   66.78	  PCV	  (4+	  doses)	   14309	   2810	   83.59	   274	   33	   89.25	  Polio	  (3+	  doses)	   15896	   1223	   92.86	   296	   11	   96.42	  Varicella	  (1+	  doses)	   15321	   1798	   89.5	   289	   18	   94.14	  Series:	  Up-­‐To-­‐Date	  Definitions	   	  	   	  	   	  	   	  	   	  	   	  	  4:3:1:3:3:1	   12731	   4388	   74.37	   231	   76	   75.24	  GA	  Requirements	   7601	   9518	   44.4	   184	   123	   59.93	  CDC	  Recommendations	   5305	   11814	   30.99	   123	   184	   40.07	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   Immunization	  rates	  nationally	  and	  in	  Georgia	  varied	  widely	  by	  definition	  of	  up-­‐to-­‐date	  status.	  	  For	  the	  most	  commonly	  used	  definition	  of	  up-­‐to-­‐date	  status	  for	  children	  in	  the	  19-­‐	  to	  35-­‐month	  age	  range	  included	  in	  the	  study	  population,	  the	  4:3:1:3:3:1	  vaccine	  series,	  the	  immunization	  coverage	  rates	  (US	  74%	  UTD,	  GA	  75%	  UTD)	  were	  higher	  than	  when	  using	  either	  of	  the	  other	  two	  definitions.	  	  For	  the	  definition	  of	  up-­‐to-­‐date	  status	  based	  on	  requirements	  for	  entry	  into	  Georgia	  public	  schools,	  in	  comparison	  with	  the	  4:3:1:3:3:1	  series	  definition	  (see	  table	  3),	  the	  hepatitis	  A	  vaccine	  is	  included,	  but	  the	  Hib	  vaccine	  is	  not.	  	  Using	  this	  definition,	  a	  fairly	  wide	  gap	  develops	  between	  the	  percentage	  considered	  up-­‐to-­‐date	  nationally	  and	  those	  considered	  up-­‐to-­‐date	  in	  Georgia.	  	  About	  44	  percent	  of	  respondents	  nationally	  and	  60	  percent	  of	  those	  in	  Georgia	  were	  considered	  up-­‐to-­‐date	  for	  age-­‐appropriate	  immunizations	  based	  on	  this	  definition.	  	  Using	  the	  CDC	  recommendations	  for	  the	  age	  group	  in	  the	  study	  population,	  which	  includes	  recommended	  doses	  of	  vaccines	  for	  each	  of	  the	  immunizations	  studied	  here,	  coverage	  rates	  drop	  even	  lower.	  	  Only	  31	  percent	  of	  respondents	  nationally	  and	  41	  percent	  of	  those	  in	  Georgia	  are	  considered	  up-­‐to-­‐date	  for	  all	  recommended	  vaccines.	  	  
 
4.2	  Associations	  and	  Background	  Information	  	   Crosstab	  analysis	  was	  conducted	  to	  examine	  the	  relationships	  between	  some	  of	  the	  variables	  studied,	  using	  survey	  data	  from	  both	  Georgia	  and	  the	  United	  States	  as	  a	  whole	  (see	  table	  8).	  	  Chi-­‐square	  statistics	  and	  p-­‐values	  were	  calculated	  for	  each	  of	  the	  associations	  explored.	  	  Nationally,	  more	  of	  the	  relationships	  found	  appear	  to	  be	  significant	  for	  the	  study	  respondents	  than	  for	  those	  using	  just	  those	  survey	  participants	  in	  Georgia.	  	  Additional	  variables	  including	  child’s	  age	  and	  provider	  information	  were	  explored	  in	  order	  to	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Table	  8.	  Crosstab	  associations	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4.3	  Research	  Questions	  1. Is	  there	  an	  association	  between	  insurance	  type	  and	  immunization	  status? 	   For	  survey	  participants	  nationwide,	  whether	  a	  child	  has	  public	  insurance	  is	  associated	  with	  all	  three	  definitions	  of	  up-­‐to-­‐date	  immunization	  status;	  the	  null	  hypothesis	  would	  be	  rejected	  for	  all	  definitions	  (see	  table	  9).	  	  There	  is	  a	  significant	  association	  between	  insurance	  type	  and	  the	  4:3:1:3:3:1	  vaccine	  series	  (χ2	  =	  15.2)	  and	  the	  vaccines	  required	  for	  public	  school	  entry	  in	  Georgia	  (χ2	  =	  10.3).	  	  The	  association	  seems	  to	  be	  stronger	  between	  insurance	  type	  and	  receipt	  of	  all	  recommended	  vaccine	  doses	  (χ2	  =	  53.2).	  	  For	  survey	  participants	  in	  Georgia,	  insurance	  type	  seems	  to	  be	  associated	  only	  with	  whether	  a	  child	  has	  received	  all	  recommended	  vaccines	  by	  age	  two	  (χ2	  =	  4.5);	  therefore,	  the	  null	  hypothesis	  that	  there	  is	  no	  association	  is	  rejected	  for	  that	  definition	  only.	  	  Insurance	  type	  does	  not	  seem	  to	  be	  associated	  with	  either	  of	  the	  other	  definitions	  of	  up-­‐to-­‐date	  immunization	  status	  in	  the	  Georgia	  sample.	  
 2. Is	  there	  an	  association	  between	  Vaccines	  for	  Children	  eligibility	  and	  immunization	  status? 	   Nationwide,	  whether	  a	  child	  is	  eligible	  for	  the	  Vaccines	  for	  Children	  program	  appears	  to	  be	  associated	  with	  whether	  that	  child	  is	  up-­‐to-­‐date	  for	  immunizations	  regardless	  of	  definition	  used;	  the	  null	  hypothesis	  is	  rejected	  for	  each	  of	  the	  variables	  used	  (see	  table	  9).	  	  The	  association	  between	  VFC	  eligibility	  and	  the	  4:3:1:3:3:1	  vaccine	  series	  is	  especially	  strong	  (χ2	  =	  160.8).	  	  As	  with	  insurance	  type,	  however,	  VFC	  eligibility	  is	  associated	  only	  with	  being	  up-­‐to-­‐date	  for	  all	  vaccines	  recommended	  by	  the	  CDC	  for	  the	  age	  group	  surveyed	  in	  Georgia	  (χ2	  =	  9.5).	  	  The	  null	  hypothesis	  that	  no	  association	  exists	  is	  	  
	   42	  
	  
Table	  9.	  Associations	  between	  insurance	  factors	  and	  up-­‐to-­‐date	  immunization	  status	  United	  States	  	   	   	   	   	   	   	   	  	   	  	   PU431331	   GA_REQ	   CDC_REC	  	   	  	   Percentage	  of	  UTD	   Percentage	  of	  UTD	   Percentage	  of	  UTD	  
Insuran
ce	   Type	   Public	  Only	   30.08%	   29.60%	   26.99%	  Private	   69.96%	   70.40%	   73.01%	  	  	   χ2	  =	  15.1557	   p	  <	  0.0001	   χ2	  =	  10.2970	   p	  =	  0.0013	   χ2	  =	  53.2135	   p	  <	  0.0001	  
VFC	   Eligibil




uity	   Not	  Con.	   6.75%	   6.47%	   5.66%	  Continuous	   93.25%	   93.53%	   94.34%	  	  	   χ2	  =	  32.2190	   p	  <	  0.0001	   χ2	  =	  17.2732	   p	  <	  0.0001	   χ2	  =	  33.7546	   p	  <	  0.0001	  	   	   	   	   	   	   	   	  Georgia	  	   	   	   	   	   	   	   	  	   	  	   PU431331	   GA_REQ	   CDC_REC	  	   	  	   Percentage	  of	  UTD	   Percentage	  of	  UTD	   Percentage	  of	  UTD	  
Insuran
ce	   Type	   Public	  Only	   30.28%	   32.18%	   23.73%	  Private	   69.72%	   67.82%	   76.27%	  	  	   χ2	  =0.0638	   p	  =	  0.8006	   χ2	  =	  0.4814	   p	  =	  0.4878	   χ2	  =	  4.5308	   p	  =	  0.0333	  
VFC	   Eligibil




uity	   Not	  Con.	   7.76%	   7.95%	   5.83%	  Continuous	   92.24%	   92.05%	   94.17%	  	  	   χ2	  =	  1.7817	   p	  =	  0.1819	   χ2	  =	  0.6347	   p	  =	  0.4256	   χ2	  =	  2.5560	   p	  =	  0.1099	  *	  Not	  ascertained	  for	  all	  observations	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rejected	  for	  this	  definition	  only	  for	  the	  Georgia	  survey	  population;	  VFC	  eligibility	  does	  not	  seem	  to	  be	  significantly	  associated	  with	  either	  of	  the	  other	  definitions	  of	  up-­‐to-­‐date	  immunization	  status.	  
 3. Is	  there	  an	  association	  between	  immunization	  status	  and	  continuity	  of	  health	  insurance? 	   In	  the	  nationwide	  survey	  population,	  lifetime	  health	  insurance	  continuity	  is	  significantly	  associated	  with	  up-­‐to-­‐date	  immunization	  status	  regardless	  of	  definition	  used	  (see	  table	  9),	  and	  the	  null	  hypothesis	  is	  rejected	  for	  each	  of	  these.	  	  The	  association	  with	  insurance	  continuity	  is	  equally	  strong	  for	  both	  the	  4:3:1:3:3:1	  vaccine	  series	  (χ2	  =	  32.2)	  and	  the	  CDC	  recommendation	  series	  (χ2	  =	  33.8).	  	  In	  Georgia,	  insurance	  continuity	  does	  not	  seem	  to	  be	  associated	  with	  up-­‐to-­‐date	  status	  (all	  χ2	  <	  3).	  	  None	  of	  the	  null	  hypotheses	  for	  this	  population	  are	  rejected.	  	  4. Which	  of	  the	  selected	  factors,	  chosen	  based	  on	  the	  literature,	  are	  most	  important	  in	  determining	  up-­‐to-­‐date	  immunization	  status? 	   Variables	  were	  selected	  based	  on	  stated	  importance	  in	  the	  literature	  and	  on	  the	  research	  questions	  proposed	  (see	  table	  10);	  null	  hypotheses	  state	  that	  the	  selected	  independent	  variable	  has	  no	  effect	  on	  the	  definition	  of	  up-­‐to-­‐date	  status	  being	  examined.	  	  Variables	  for	  which	  the	  null	  hypothesis	  was	  rejected	  seem	  to	  be	  important	  in	  predicting	  up-­‐to-­‐date	  status	  based	  on	  the	  particular	  definition	  and	  population.	  	  Overall,	  child’s	  age	  appears	  to	  be	  the	  single	  most	  important	  predictor	  of	  up-­‐to-­‐date	  immunization	  status	  and	  was	  significant	  for	  five	  of	  the	  six	  groups	  (for	  PU431331	  in	  GA,	  p	  =	  0.4699;	  all	  other	  p	  <	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0.0001).	  	  Nationally,	  child’s	  race/ethnicity	  was	  a	  significant	  predictor	  of	  two	  definitions	  of	  up-­‐to-­‐date	  status	  (GA_REQ	  p	  =	  0.0305,	  CDC_REC	  p	  <	  0.0001).	  	  Mother’s	  education	  appears	  to	  be	  significant	  only	  when	  predicting	  whether	  a	  child	  had	  received	  all	  of	  the	  vaccines	  recommended	  by	  the	  CDC,	  both	  nationally	  and	  in	  Georgia.	  	  Insurance	  continuity	  seemed	  to	  be	  a	  significant	  predictor	  in	  the	  national	  sample	  (p	  <	  0.0001	  for	  all	  definitions),	  but	  was	  not	  significant	  among	  respondents	  in	  Georgia.	  	  Household	  poverty	  status	  was	  also	  not	  significant	  in	  the	  Georgia	  sample,	  but	  was	  appeared	  to	  be	  somewhat	  important	  in	  predicting	  4:3:1:3:3:1	  series	  and	  CDC	  recommendations	  receipt	  in	  the	  national	  sample.	  	  Despite	  some	  suggestion	  in	  the	  literature,	  mother’s	  marital	  status	  did	  not	  appear	  to	  be	  a	  predictor	  of	  up-­‐to-­‐date	  immunization	  status	  at	  all.	  	  Whether	  a	  child	  had	  public	  or	  private	  insurance	  also	  did	  not	  seem	  to	  be	  an	  important	  predictor	  of	  up-­‐to-­‐date	  status.	  Nationally,	  using	  the	  4:3:1:3:3:1	  series	  to	  define	  up-­‐to-­‐date	  immunization	  status,	  the	  null	  hypothesis	  was	  rejected	  for	  child’s	  age	  group,	  household	  poverty	  status,	  insurance	  continuity,	  and	  number	  of	  vaccine	  providers.	  	  Defining	  up-­‐to-­‐date	  status	  based	  on	  entry	  requirements	  to	  Georgia	  public	  schools,	  the	  null	  hypothesis	  is	  rejected	  for	  child’s	  age	  group,	  child’s	  race/ethnicity,	  insurance	  continuity,	  and	  number	  of	  vaccine	  providers.	  	  Using	  the	  definition	  based	  on	  all	  immunizations	  recommended	  by	  the	  CDC	  for	  the	  age	  group	  surveyed,	  the	  null	  hypothesis	  was	  rejected	  for	  child’s	  age	  group,	  child’s	  race/ethnicity,	  mother’s	  education,	  household	  poverty	  status,	  insurance	  continuity,	  and	  number	  of	  vaccine	  providers.	  	   For	  the	  survey	  population	  in	  Georgia,	  fewer	  variables	  seemed	  to	  be	  important	  predictors	  of	  up-­‐to-­‐date	  immunization	  status	  for	  each	  of	  the	  definitions	  used.	  	  Using	  the	  4:3:1:3:3:1	  vaccine	  series	  to	  define	  up-­‐to-­‐date	  status,	  no	  null	  hypotheses	  are	  rejected.	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Defining	  up-­‐to-­‐date	  status	  based	  on	  requirements	  for	  entry	  to	  Georgia	  public	  schools,	  the	  null	  hypothesis	  for	  child’s	  age	  group	  is	  rejected.	  	  Basing	  up-­‐to-­‐date	  status	  on	  the	  CDC’s	  recommendations	  for	  all	  vaccines	  for	  the	  age	  group	  surveyed,	  null	  hypotheses	  are	  rejected	  for	  child’s	  age	  group	  and	  mother’s	  level	  of	  education.	  
 
Table	  10.	  Logistic	  regression	  results,	  US	  and	  Georgia;	  Odds	  ratio	  and	  confidence	  interval	  
	   	  	   United	  States	   Georgia	  	  	   	  	   PU431331	   GA_REQ	   CDC_REC	   PU431331	   GA_REQ	   CDC_REC	  Child's	  Age	  Group	   OR	   1.151	   1.893	   1.422	   1.144	   2.655	   1.96	  95%	  CI	   (1.101,	  1.204)*	   (1.817,	  1.973)*	   (1.363,	  1.484)*	   (0.794,	  1.649)	   (1.852,	  3.808)*	   (1.385,	  2.772)*	  	   	  	   	  	   	   	  	   	   	   	  Child's	  Race	  /	  Ethnicity	   OR	   0.971	   0.957	   0.914	   0.936	   1.071	   0.865	  95%	  CI	   (0.93,	  1.015)	   (0.92,	  0.996)*	   (0.875,	  0.953)*	   (0.647,	  1.356)	   (0.754,	  1.523)	   (0.611,	  1.225)	  	   	  	   	  	   	   	  	   	   	   	  Mother's	  Education	   OR	   1.011	   0.971	   1.058	   1.066	   1.345	   1.524	  95%	  CI	   (0.965,	  1.059)	   (0.931,	  1.012)	   (1.012,	  1.106)*	   (0.76,	  1.495)	   (0.969,	  1.866)	   (1.092,	  2.127)*	  	   	  	   	  	   	   	  	   	   	   	  Mother's	  Marital	  Status	   OR	   0.957	   0.915	   0.915	   1.033	   0.835	   0.59	  95%	  CI	   (0.867,	  1.056)	   (0.837,	  1.001)	   (0.83,	  1.007)	   (0.475,	  2.243)	   (0.395,	  1.766)	   (0.28,	  1.247)	  	   	  	   	  	   	   	  	   	   	   	  Household	  Poverty	  Status	   OR	   0.906	   0.964	   0.932	   1.034	   1.247	   1.081	  95%	  CI	   (0.858,	  0.958)*	   (0.917,	  1.013)	   (0.884,	  0.982*)	   (0.695,	  1.537)	   (0.848,	  1.833)	   (0.748,	  1.563)	  	   	  	   	  	   	   	  	   	   	   	  Insurance	  Type	   OR	   0.996	   1.052	   1.078	   0.995	   0.642	   0.902	  95%	  CI	   (0.901,	  1.101)	   (0.96,	  1.152)	   (0.978,	  1.189)	   (0.449,	  2.205)	   (0.297,	  1.387)	   (0.418,	  1.944)	  	   	  	   	  	   	   	  	   	   	   	  Insurance	  Continuity	   OR	   1.428	   1.323	   1.387	   1.814	   1.878	   1.976	  95%	  CI	   (1.251,	  1.629)*	   (1.165,	  1.503)*	   (1.204,	  1.597)*	   (0.734,	  4.48)	   (0.743,	  4.742)	   (0.734,	  5.319)	  	   	  	   	  	   	   	  	   	   	   	  Number	  of	  Vaccine	  Providers	   OR	   1.46	   1.234	   1.129	   1.07	   1.701	   1.599	  95%	  CI	   (1.351,	  1.578)*	   (1.159,	  1.315)*	   (1.057,	  1.205)*	   (0.615,	  1.865)	   (0.983,	  2.945)	   (0.961,	  2.66)	  	   *	  Statistically	  Significant	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CHAPTER	  V	  
DISCUSSION	  AND	  CONCLUSION	  
 	   Vaccines	  have	  greatly	  reduced	  the	  morbidity	  and	  mortality	  associated	  with	  infectious	  diseases.	  	  However,	  vaccine-­‐preventable	  diseases	  still	  occur	  in	  the	  United	  States,	  and	  disparities	  exist	  among	  children	  who	  are	  up-­‐to-­‐date	  for	  recommended	  immunizations.	  	  It	  is	  important	  to	  ensure	  that	  immunization	  rates	  remain	  high	  and	  that	  all	  children	  are	  able	  to	  readily	  access	  appropriate	  vaccines	  (CDC,	  1999).	  	  Imported	  cases	  of	  infectious	  disease	  (CDC,	  2008a),	  oft-­‐changing	  public	  perception	  of	  vaccines	  (Stern	  &	  Markel,	  2005),	  and	  economic	  barriers	  (Zimmerman,	  et	  al.,	  2006)	  remain	  challenges	  to	  protecting	  children	  in	  the	  US	  from	  infectious	  diseases.	  	  The	  Healthy	  People	  2020	  publication	  has	  listed	  childhood	  immunization	  coverage	  rate	  targets,	  some	  which	  have	  been	  met	  and	  must	  be	  maintained,	  and	  some	  that	  have	  not	  yet	  been	  achieved	  (DHHS).	  	  Health	  insurance	  status	  –	  including	  whether	  a	  child	  does	  or	  does	  not	  have	  insurance,	  whether	  that	  insurance	  is	  public	  or	  private,	  and	  whether	  insurance	  coverage	  is	  continuous	  over	  time	  –	  has	  previously	  been	  seen	  to	  be	  associated	  with	  immunization	  uptake	  and	  whether	  a	  child	  is	  up-­‐to-­‐date	  for	  recommended	  childhood	  immunizations	  (Deutchman,	  Brayden,	  Siegel,	  Beaty,	  &	  Crane,	  2000;	  Zimmerman,	  et	  al.,	  2006;	  Blewett,	  Davidson,	  Bramlett,	  Rodin,	  &	  Messonnier,	  2008;	  Smith,	  Stevenson,	  &	  Chu,	  2006).	  The	  introduction	  of	  the	  State	  Children’s	  Health	  Insurance	  Program	  (SCHIP)	  and	  the	  Vaccines	  for	  Children	  (VFC)	  program	  should	  be	  working	  to	  close	  the	  gap	  between	  those	  children	  who	  are	  fully	  immunized	  and	  those	  who	  are	  not.	  	  The	  VFC	  program	  in	  particular	  should	  be	  having	  the	  effect	  of	  eliminating	  the	  association	  between	  insurance	  status	  and	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immunization	  uptake.	  	  The	  purpose	  of	  this	  study	  was	  to	  address	  whether	  insurance	  status	  has	  an	  effect	  on	  immunization	  uptake,	  by	  investigating	  associations	  between	  vaccine	  receipt	  and	  insurance	  type,	  Vaccines	  for	  Children	  eligibility,	  and	  insurance	  continuity.	  Crosstab,	  chi-­‐squared,	  and	  logistic	  regression	  analyses	  were	  performed	  on	  data	  from	  the	  2010	  National	  Immunization	  Survey	  using	  SAS	  9.2.	  	  Up-­‐to-­‐date	  immunization	  status	  was	  determined	  using	  three	  definitions:	  the	  4:3:1:3:3:1	  vaccine	  series;	  requirements	  for	  entry	  into	  Georgia	  public	  schools,	  age-­‐adjusted	  to	  fit	  the	  survey	  population;	  and	  all	  vaccines	  recommended	  for	  all	  children	  by	  the	  CDC.	  	  Insurance	  type,	  Vaccines	  for	  Children	  program	  eligibility,	  and	  insurance	  continuity	  were	  examined	  for	  associations	  with	  each	  of	  the	  three	  definitions	  of	  up-­‐to-­‐date	  immunization	  status.	  	  Logistic	  regression	  was	  performed	  using	  each	  of	  those	  factors	  as	  well	  as	  others	  suggested	  by	  the	  literature,	  such	  as	  mother’s	  education	  level	  and	  household	  poverty	  status.	  	  The	  goal	  of	  the	  logistic	  regression	  was	  not	  to	  determine	  the	  best	  model	  for	  predicting	  up-­‐to-­‐date	  status,	  but	  simply	  to	  further	  investigate	  the	  variables	  being	  studied.	  
 
5.1	  Sociodemographic	  Factors	  	   Demographic	  factors	  were	  not	  examined	  at	  length	  with	  respect	  to	  their	  importance	  in	  predicting	  up-­‐to-­‐date	  immunization	  status;	  this	  analysis	  generally	  focused	  on	  insurance-­‐related	  variables.	  	  However,	  some	  sociodemographic	  and	  economic	  variables	  were	  included	  in	  order	  to	  gain	  a	  more	  in-­‐depth	  understanding	  of	  factors	  that	  are	  generally	  considered	  to	  be	  important	  predictors	  of	  immunization	  uptake.	  	  A	  child’s	  age	  group	  was	  found	  to	  be	  a	  strong	  and	  significant	  predictor	  of	  up-­‐to-­‐date	  status	  in	  all	  models	  except	  the	  one	  predicting	  completion	  of	  the	  4:3:1:3:3:1	  vaccine	  series	  in	  respondents	  in	  Georgia.	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Survey	  respondents	  fell	  into	  one	  of	  three	  age	  groups:	  19	  to	  23	  months,	  24	  to	  29	  months,	  or	  30	  to	  35	  months.	  	  About	  28	  percent	  of	  respondents	  nationally	  (and	  28%	  in	  Georgia)	  were	  between	  19	  and	  23	  months	  of	  age;	  about	  35	  percent	  (40%)	  were	  between	  24	  and	  29	  months	  of	  age;	  and	  about	  36	  percent	  (32%)	  were	  between	  30	  and	  35	  months	  of	  age.	  	  If	  all	  doses	  of	  each	  vaccine	  are	  given	  at	  the	  recommended	  time,	  each	  child	  should	  be	  up-­‐to-­‐date	  for	  all	  vaccines	  recommended	  for	  2-­‐	  to	  3-­‐year-­‐olds	  by	  18	  months	  of	  age	  and	  before	  becoming	  eligible	  for	  participation	  in	  the	  National	  Immunization	  Survey.	  	  In	  this	  analysis,	  however,	  older	  children	  were	  more	  likely	  to	  be	  up-­‐to-­‐date.	  	  Therefore,	  it	  seems	  clear	  that	  even	  when	  children	  are	  receiving	  all	  of	  the	  recommended	  vaccines,	  they	  are	  not	  necessarily	  receiving	  them	  on	  the	  timeline	  recommended	  by	  the	  CDC.	  	  The	  rationale	  behind	  this	  is	  not	  evident	  from	  this	  analysis;	  indeed,	  it	  is	  unclear	  whether	  the	  association	  between	  age	  group	  and	  up-­‐to-­‐date	  status	  is	  having	  a	  positive	  or	  negative	  impact	  on	  overall	  immunization	  coverage	  rates.	  	  For	  those	  children	  receiving	  vaccines	  later	  than	  recommended	  who	  may	  be	  missing	  well-­‐child	  care	  visits	  due	  to	  economic	  or	  transportation	  issues,	  it	  would	  seem	  that	  providers	  are	  taking	  advantage	  of	  sick	  visits	  to	  provide	  vaccinations	  for	  children	  who	  might	  not	  otherwise	  receive	  them.	  	  Alternately,	  such	  an	  association	  could	  suggest	  that	  in	  general,	  recommendations	  are	  not	  being	  closely	  followed	  by	  parents	  or	  providers,	  which	  could	  lead	  to	  some	  children	  missing	  important	  vaccines	  altogether.	  	   A	  child’s	  race/ethnicity	  was	  found	  to	  be	  an	  important	  predictor	  among	  national	  respondents	  for	  receipt	  of	  all	  recommended	  vaccines,	  and	  a	  significant	  but	  not	  very	  strong	  predictor	  of	  up-­‐to-­‐date	  status	  for	  immunization	  requirements	  for	  Georgia	  public	  schools.	  Race/ethnicity	  was	  not	  a	  significant	  predictor	  for	  any	  up-­‐to-­‐date	  status	  definition	  among	  respondents	  in	  Georgia,	  which	  were	  more	  likely	  to	  be	  non-­‐Hispanic	  black	  only	  and	  less	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likely	  to	  be	  Hispanic	  or	  non-­‐Hispanic	  white	  only.	  	  Research	  has	  indicated	  that	  race/ethnicity	  is	  often	  an	  important	  indicator	  of	  health	  outcomes.	  	  However,	  it	  is	  possible	  that	  it	  may	  be	  more	  important	  in	  the	  context	  of	  other	  socioeconomic	  variables	  than	  it	  is	  directly	  responsible	  for	  the	  immunization	  status;	  confounding	  variables	  were	  not	  examined	  in-­‐depth	  in	  this	  analysis.	  In	  the	  logistic	  regression	  analysis,	  mother’s	  level	  of	  education	  was	  found	  to	  be	  a	  significant	  predictor	  of	  up-­‐to-­‐date	  immunization	  status	  only	  for	  all	  CDC-­‐recommended	  vaccines	  for	  survey	  participants	  both	  nationally	  and	  in	  Georgia.	  	  Children	  of	  better-­‐educated	  mothers	  were	  most	  likely	  to	  be	  up-­‐to-­‐date	  for	  all	  universally	  recommended	  vaccines.	  	  The	  lack	  of	  significance	  of	  mother’s	  education	  level	  for	  the	  4:3:1:3:3:1	  series	  might	  suggest	  that	  providers	  are	  generally	  doing	  a	  decent	  job	  of	  explaining	  the	  importance	  of	  this	  commonly-­‐cited	  series	  of	  vaccines	  to	  mothers.	  	  This	  in	  turn	  may	  be	  leading	  to	  children	  more	  often	  receiving	  the	  appropriate	  doses	  of	  these	  vaccines	  regardless	  of	  mother’s	  education	  level.	  	  Mother’s	  education	  level	  is	  also	  not	  a	  significant	  predictor	  of	  whether	  a	  child	  has	  received	  the	  age-­‐appropriate	  doses	  of	  vaccines	  required	  for	  entry	  into	  Georgia	  public	  schools;	  this	  indicates	  that	  information	  regarding	  vaccines	  mandated	  for	  school	  entry	  may	  be	  reaching	  parents	  regardless	  of	  their	  education	  level.	  	  However,	  the	  analysis	  indicates	  that	  children	  of	  better-­‐educated	  mothers	  are	  more	  likely	  to	  have	  received	  the	  full	  complement	  of	  recommended	  vaccines.	  	  This	  could	  be	  due	  to	  better-­‐educated	  mothers	  making	  themselves	  more	  aware	  of	  the	  importance	  of	  immunization	  overall.	  	  This	  significance,	  however,	  might	  also	  indicate	  that	  while	  providers	  seem	  to	  be	  communicating	  with	  all	  mothers	  regarding	  well-­‐known	  series	  and	  school	  mandates,	  they	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are	  not	  effectively	  communicating	  the	  importance	  of	  all	  recommended	  immunizations	  to	  less-­‐educated	  mothers.	  	  	  Contrary	  to	  what	  has	  been	  suggested	  in	  previous	  research,	  mother’s	  marital	  status	  was	  not	  found	  to	  be	  a	  significant	  predictor	  of	  up-­‐to-­‐date	  status	  using	  any	  of	  the	  models.	  	  It	  is	  possible	  that	  mother’s	  marital	  status	  is	  becoming	  an	  increasingly	  less	  accurate	  means	  of	  predicting	  health	  outcomes	  due	  to	  changing	  family	  dynamics.	  	  Recent	  census	  data	  has	  revealed	  that	  marriage	  rates	  have	  slowed;	  the	  percentage	  of	  unmarried	  couples	  is	  increasing	  for	  economic	  and	  other	  reasons	  (El	  Nasser	  &	  Overberg,	  2011).	  	  Additionally,	  multigenerational	  families	  are	  becoming	  more	  common,	  and	  “the	  most	  common	  multigenerational	  family	  is	  an	  older	  parent	  who	  owns	  the	  house,	  living	  with	  an	  adult	  child	  and	  grandchild	  (CBS	  News,	  2010).”	  	  It	  can	  be	  assumed	  that	  unmarried	  mothers	  living	  with	  partners	  or	  extended	  family	  are	  receiving	  some	  measure	  of	  financial	  or	  emotional	  support	  that	  is	  allowing	  them	  to	  ensure	  their	  children	  are	  immunized.	  	  A	  more	  appropriate	  measure	  to	  predict	  health	  outcomes	  might	  be	  the	  number	  of	  adults	  in	  the	  household.	  	  Due	  to	  the	  nature	  of	  this	  data	  set,	  it	  was	  not	  possible	  to	  compute	  such	  a	  variable	  for	  this	  analysis;	  however,	  as	  mother’s	  marital	  status	  did	  not	  seem	  to	  be	  a	  significant	  factor	  it	  should	  be	  considered	  in	  future	  research.	  	   Household	  poverty	  status	  was	  also	  included	  in	  the	  logistic	  regression	  models.	  	  In	  this	  data	  set,	  poverty	  status	  has	  been	  coded	  into	  three	  categories:	  below	  poverty	  line,	  above	  poverty	  line	  but	  below	  $75,000	  per	  year,	  and	  above	  $75,000	  per	  year.	  	  Georgia	  respondents	  were	  slightly	  more	  likely	  to	  be	  living	  below	  the	  poverty	  line	  than	  the	  national	  sample.	  	  In	  the	  logistic	  regression	  analysis,	  household	  poverty	  status	  was	  a	  significant,	  but	  not	  very	  strong,	  predictor	  of	  up-­‐to-­‐date	  status	  for	  the	  4:3:1:3:3:1	  series	  and	  all	  CDC-­‐recommended	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vaccines	  for	  the	  national	  sample.	  	  The	  lack	  of	  strong	  association	  might	  indicate	  that	  although	  poverty	  is	  known	  to	  be	  an	  important	  predictor	  of	  many	  health	  outcomes,	  programs	  put	  in	  place	  to	  address	  disparities	  in	  immunization	  uptake	  have	  been	  reducing	  the	  impact	  of	  poverty	  on	  up-­‐to-­‐date	  status.	  	   The	  number	  of	  vaccine	  providers	  responding	  to	  the	  written	  questionnaire	  for	  each	  child	  was	  seen	  in	  the	  logistic	  regression	  to	  be	  a	  strong	  and	  significant	  predictor	  of	  up-­‐to-­‐date	  status	  in	  the	  national	  sample	  for	  each	  of	  the	  three	  definitions	  used;	  children	  with	  a	  single	  vaccine	  provider	  were	  most	  likely	  to	  be	  up-­‐to-­‐date.	  	  This	  association	  was	  also	  seen	  to	  be	  significant	  in	  the	  crosstab	  analysis.	  	  Additionally,	  a	  child’s	  number	  of	  vaccine	  providers	  was	  significantly	  associated	  with	  whether	  adequate	  provider	  data	  was	  available	  to	  determine	  up-­‐to-­‐date	  immunization	  status	  among	  respondents	  nationally	  and	  in	  Georgia.	  	  This	  seems	  to	  go	  along	  with	  previous	  research,	  which	  has	  suggested	  that	  increased	  number	  of	  providers	  leads	  to	  poorer	  record	  keeping;	  both	  may	  lead	  lower	  chances	  of	  being	  up-­‐to-­‐date	  for	  immunizations	  (Deutchman,	  Brayden,	  Siegel,	  Beaty,	  &	  Crane,	  2000). 
 
5.2	  Insurance	  Type	  Historically,	  children	  with	  private	  insurance	  have	  higher	  immunization	  rates,	  better	  access	  to	  care,	  and	  improved	  health	  outcomes	  over	  children	  with	  public	  insurance	  such	  as	  Medicaid.	  	  Children	  with	  public	  insurance	  are	  more	  likely	  to	  be	  referred	  to	  additional	  providers	  for	  vaccines	  (Deutchman,	  Brayden,	  Siegel,	  Beaty,	  &	  Crane,	  2000),	  and	  insurance	  type	  and	  immunization	  status	  remain	  associated	  (Zimmerman,	  et	  al.,	  2006;	  Blewett,	  Davidson,	  Bramlett,	  Rodin,	  &	  Messonnier,	  2008),	  despite	  programs	  in	  place	  to	  address	  both	  of	  these	  problems.	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In	  the	  2010	  National	  Immunization	  Survey	  sample,	  approximately	  30	  percent	  of	  children	  had	  been	  covered	  only	  by	  public	  health	  insurance	  throughout	  their	  lifetime;	  the	  rest	  of	  the	  children	  had	  been	  covered	  by	  private	  health	  insurance	  at	  some	  point.	  	  Of	  all	  types	  of	  insurance,	  the	  majority	  of	  respondents	  were	  covered	  under	  insurance	  through	  their	  parents’	  employer	  or	  union,	  although	  this	  does	  not	  necessarily	  indicate	  permanent	  private	  health	  insurance	  coverage.	  	  In	  this	  analysis,	  insurance	  type	  was	  found	  to	  be	  associated	  with	  all	  three	  definitions	  of	  up-­‐to-­‐date	  status	  in	  the	  national	  sample	  and	  with	  whether	  a	  child	  had	  received	  all	  recommended	  vaccines	  among	  respondents	  in	  Georgia.	  	  Despite	  reported	  trends	  of	  declining	  importance	  (Zhao,	  Mokdad,	  &	  Barker,	  2004;	  Blewett,	  Davidson,	  Bramlett,	  Rodin,	  &	  Messonnier,	  2008;	  Smith,	  Stevenson,	  &	  Chu,	  2006),	  it	  appears	  that	  whether	  a	  child	  has	  public	  or	  private	  health	  insurance	  is	  still	  associated	  with	  whether	  that	  child	  receives	  recommended	  immunizations;	  those	  children	  with	  only	  public	  health	  insurance	  were	  less	  often	  up-­‐to-­‐date	  in	  the	  sample.	  	  However,	  in	  the	  logistic	  regression	  analysis,	  insurance	  type	  was	  not	  found	  to	  be	  a	  significant	  predictor	  of	  whether	  a	  child	  was	  up-­‐to-­‐date	  for	  recommended	  immunizations	  when	  considered	  along	  with	  the	  other	  variables	  included.	  	  This	  suggests	  that	  although	  an	  association	  between	  insurance	  type	  and	  up-­‐to-­‐date	  status	  appears	  to	  still	  be	  present,	  whether	  a	  child	  has	  public	  or	  private	  insurance	  may	  be	  no	  longer	  one	  of	  the	  most	  important	  factors	  in	  determining	  whether	  a	  child	  will	  receive	  the	  recommended	  vaccines.	  Insurance	  type	  was	  also	  found	  in	  this	  analysis	  to	  be	  associated	  in	  the	  national	  sample	  with	  the	  number	  of	  vaccine	  providers	  seen	  by	  a	  child.	  	  This	  suggests	  that	  either	  those	  with	  public	  health	  insurance	  are	  less	  able	  to	  find	  or	  maintain	  a	  primary	  health	  care	  home,	  or	  that	  providers	  remain	  more	  likely	  to	  refer	  children	  with	  public	  health	  care	  to	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alternative	  care	  sites	  for	  vaccines,	  or	  that	  both	  issues	  are	  occurring.	  	  It	  is	  possible	  that	  the	  tendency	  to	  refer	  children	  to	  additional	  providers	  is	  exacerbating	  the	  socioeconomic	  disparities	  that	  exist	  in	  immunization	  receipt.	  	  This	  analysis	  does	  not	  take	  into	  consideration	  all	  possible	  underlying	  or	  confounding	  causes;	  however,	  it	  is	  clear	  opportunities	  remain	  to	  improve	  immunization	  rates	  among	  children	  with	  public	  health	  insurance.	  	  Also,	  as	  long	  as	  factors	  such	  as	  number	  of	  providers	  remain	  associated	  with	  both	  immunization	  uptake	  and	  insurance	  type,	  focusing	  interventions	  on	  children	  with	  public	  health	  care	  may	  still	  provide	  one	  of	  the	  best	  opportunities	  for	  improving	  childhood	  immunization	  rates	  overall.	  
 
5.3	  Vaccines	  For	  Children	  Eligibility	  The	  Vaccines	  for	  Children	  program	  was	  implemented	  in	  1994	  to	  eliminate	  socioeconomic	  disparities	  in	  immunization	  coverage	  rates.	  	  If	  a	  health	  care	  provider	  participates	  in	  the	  VFC	  program,	  the	  provider	  can	  order	  vaccines	  at	  no	  cost	  through	  the	  program	  to	  be	  used	  for	  children	  who	  are	  eligible	  to	  receive	  them.	  	  To	  be	  eligible	  to	  receive	  VFC	  vaccines,	  a	  child	  must	  be	  eligible	  for	  Medicaid,	  uninsured,	  American	  Indian	  or	  Alaska	  Native,	  or	  underinsured,	  meaning	  that	  the	  child	  has	  private	  insurance	  but	  vaccines	  are	  not	  completely	  covered	  (CDC,	  2011a).	  	  Research	  has	  shown	  that	  thus	  far,	  despite	  overall	  improvements	  in	  immunization	  coverage	  rates,	  children	  who	  are	  VFC	  eligible	  have	  remained	  less	  likely	  to	  receive	  the	  full	  complement	  of	  immunizations	  (Zimmerman,	  et	  al.,	  2006;	  Blewett,	  Davidson,	  Bramlett,	  Rodin,	  &	  Messonnier,	  2008).	  In	  the	  2010	  National	  Immunization	  Survey	  population,	  37.4	  percent	  of	  respondents	  overall	  and	  38.2	  percent	  of	  those	  in	  Georgia	  were	  deemed	  eligible	  for	  the	  VFC	  program.	  	  In	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this	  analysis,	  children	  who	  were	  eligible	  for	  the	  VFC	  program	  were	  less	  likely	  to	  be	  fully	  immunized	  than	  ineligible	  children.	  	  VFC	  eligibility	  was	  found	  to	  be	  significantly	  associated	  with	  all	  three	  up-­‐to-­‐date	  status	  definitions	  in	  the	  national	  survey	  population.	  	  In	  Georgia,	  VFC	  eligibility	  was	  found	  to	  be	  associated	  with	  whether	  a	  child	  had	  received	  all	  vaccines	  recommended	  by	  the	  CDC.	  	  The	  VFC	  program	  was	  created	  to	  improve	  immunization	  rates	  by	  addressing	  the	  needs	  of	  “children	  who	  might	  not	  otherwise	  receive	  vaccines	  because	  of	  financial	  barriers	  or	  who	  might	  receive	  vaccines	  late	  because	  they	  would	  be	  referred	  to	  another	  setting	  for	  free	  vaccines	  (GA	  DPH,	  2010).”	  	  Almost	  40%	  of	  children	  surveyed	  were	  eligible	  for	  the	  program,	  and	  these	  children	  were	  less	  likely	  to	  be	  up-­‐to-­‐date	  than	  those	  who	  were	  not	  eligible	  regardless	  of	  definition	  used.	  	  In	  general,	  whether	  a	  child	  is	  eligible	  for	  the	  Vaccines	  for	  Children	  program	  seems	  to	  still	  be	  associated	  with	  up-­‐to-­‐date	  immunization	  status;	  as	  yet,	  a	  gap	  still	  exists.	  	  This	  suggests	  that	  there	  remain	  opportunities	  to	  improve	  the	  overall	  effectiveness	  of	  the	  VFC	  program.	  	  	  If	  the	  program	  was	  having	  the	  maximum	  intended	  impact,	  there	  should	  be	  no	  association	  between	  VFC	  eligibility	  and	  immunization	  uptake;	  children	  who	  are	  eligible	  to	  receive	  VFC	  vaccines	  would	  be	  receiving	  them	  at	  least	  as	  often	  as	  those	  who	  are	  not	  eligible.	  	  This	  analysis	  only	  looks	  at	  2010,	  the	  most	  recent	  year	  for	  which	  data	  are	  available;	  therefore	  improvement	  over	  time	  cannot	  be	  commented	  on.	  	  This	  analysis	  also	  does	  not	  investigate	  all	  other	  causes	  which	  may	  be	  contributing	  to	  the	  persistent	  socioeconomic	  gap;	  however,	  some	  rationales	  suggested	  by	  the	  literature	  reviewed	  include	  limited	  access	  to	  care,	  referrals	  to	  alternate	  providers	  for	  vaccines,	  and	  provider	  failure	  to	  vaccinate	  children	  at	  sick	  visits	  who	  might	  be	  unable	  to	  return	  for	  additional	  well	  visits.	  	  Despite	  these	  
	   55	  
limitations,	  however,	  it	  seems	  that	  continued	  progress	  is	  necessary	  to	  maximize	  the	  impact	  of	  the	  Vaccines	  for	  Children	  program.	  
 
5.4	  Insurance	  Continuity	  	   Research	  has	  shown	  that	  as	  programs	  narrow	  the	  gap	  in	  up-­‐to-­‐date	  immunization	  status	  between	  children	  who	  have	  private	  insurance	  and	  those	  who	  do	  not,	  insurance	  continuity	  is	  becoming	  an	  increasingly	  important	  factor	  in	  whether	  children	  are	  up-­‐to-­‐date.	  	  Children	  who	  experience	  gaps	  in	  health	  insurance	  coverage	  have	  been	  shown	  to	  be	  less	  likely	  to	  receive	  recommended	  immunizations,	  sometimes	  regardless	  of	  insurance	  type	  (Blewett,	  Davidson,	  Bramlett,	  Rodin,	  &	  Messonnier,	  2008;	  Smith,	  Stevenson,	  &	  Chu,	  2006).	  	  In	  analysis	  of	  2001	  and	  2002	  NIS	  data,	  Smith,	  Stevenson,	  and	  Chu	  found	  that	  13	  percent	  of	  children	  were	  uninsured	  at	  some	  point	  in	  time.	  In	  the	  2010	  NIS	  sample,	  fewer	  than	  10	  percent	  of	  children	  were	  reported	  to	  have	  experienced	  gaps	  in	  health	  insurance	  coverage	  in	  their	  lifetimes.	  	  Insurance	  continuity	  was	  found	  to	  be	  associated	  in	  the	  national	  survey	  population	  with	  up-­‐to-­‐date	  immunization	  status	  when	  using	  any	  of	  the	  three	  definitions.	  	  Overall,	  children	  whose	  insurance	  coverage	  was	  not	  continuous	  were	  less	  likely	  to	  be	  up-­‐to-­‐date	  than	  children	  who	  had	  experienced	  uninterrupted	  coverage.	  	  Although	  that	  likelihood	  was	  seen	  in	  respondents	  in	  Georgia	  as	  well,	  in	  this	  analysis	  insurance	  continuity	  was	  not	  found	  to	  be	  associated	  with	  immunization	  status	  for	  that	  group.	  	  This	  association	  between	  insurance	  continuity	  and	  up-­‐to-­‐date	  status	  in	  the	  national	  sample	  held	  true	  in	  the	  logistic	  regression	  analysis	  as	  well;	  insurance	  continuity	  was	  found	  to	  be	  a	  strong	  and	  significant	  predictor	  of	  whether	  children	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were	  up-­‐to-­‐date	  by	  any	  definition	  used,	  but	  was	  not	  found	  to	  be	  a	  significant	  predictor	  of	  up-­‐to-­‐date	  status	  in	  respondents	  from	  Georgia.	  
 
5.5	  Up-­‐To-­‐Date	  Status	  Definition	  
	   Whether	  a	  child	  was	  considered	  up-­‐to-­‐date	  for	  recommended	  immunizations	  varied	  widely	  depending	  on	  which	  definition	  was	  used.	  	  Overall,	  children	  were	  much	  more	  likely	  to	  be	  considered	  to	  be	  up-­‐to-­‐date	  when	  using	  receipt	  of	  the	  full	  4:3:1:3:3:1	  vaccine	  series	  as	  the	  defining	  factor.	  	  The	  4:3:1:3:3:1	  series	  includes	  the	  DTaP,	  hepatitis	  B,	  MMR,	  rotavirus,	  polio,	  and	  varicella	  vaccines;	  approximately	  three-­‐quarters	  of	  children	  included	  in	  the	  survey	  were	  up-­‐to-­‐date	  for	  this	  series.	  	  Using	  the	  age-­‐adjusted	  requirements	  for	  entry	  into	  Georgia	  public	  schools,	  which	  excludes	  the	  rotavirus	  vaccine	  but	  adds	  the	  hepatitis	  A	  vaccine,	  fewer	  children	  in	  the	  sample	  can	  be	  considered	  up-­‐to-­‐date	  (US	  44.4%,	  GA	  59.9%).	  	  When	  looking	  at	  up-­‐to-­‐date	  receipt	  of	  all	  CDC-­‐recommended	  vaccines,	  which	  includes	  all	  vaccines	  in	  the	  previous	  two	  definitions	  as	  well	  as	  the	  Hib	  vaccine	  and	  the	  PCV,	  even	  fewer	  children	  can	  be	  considered	  up-­‐to-­‐date	  (US	  30.9%,	  GA	  40%).	  	   To	  begin	  to	  understand	  the	  rationale	  behind	  the	  wide	  variation	  in	  up-­‐to-­‐date	  status	  according	  to	  definition,	  it	  is	  necessary	  to	  look	  at	  the	  individual	  vaccines	  included	  in	  each	  definition.	  	  The	  4:3:1:3:3:1	  series,	  often	  used	  to	  determine	  up-­‐to-­‐date	  status,	  includes	  mostly	  vaccines	  with	  relatively	  high	  coverage	  rates:	  in	  the	  2010	  NIS	  survey	  population,	  at	  least	  about	  85	  percent	  of	  children	  were	  up-­‐to-­‐date	  for	  each	  of	  the	  individual	  vaccines	  with	  the	  exception	  of	  only	  the	  rotavirus	  vaccine,	  for	  which	  over	  60	  percent	  of	  participants	  were	  up-­‐to-­‐date.	  	  In	  comparison,	  the	  Georgia	  public	  school	  requirements	  do	  not	  include	  the	  rotavirus	  vaccine,	  but	  do	  include	  the	  vaccine	  for	  hepatitis	  A,	  which	  has	  even	  lower	  coverage	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among	  respondents	  at	  48	  percent	  up-­‐to-­‐date.	  	  When	  looking	  at	  all	  CDC-­‐recommended	  vaccines,	  both	  of	  these	  low-­‐coverage	  vaccines	  are	  included.	  	   While	  this	  analysis	  does	  not	  investigate	  the	  rationale	  behind	  the	  differences	  with	  respect	  to	  definition,	  it	  is	  likely	  that	  some	  of	  the	  difference	  can	  be	  explained	  by	  the	  age	  of	  the	  vaccines;	  newer	  vaccines	  tend	  to	  have	  lower	  coverage	  rates.	  	  The	  hepatitis	  A	  vaccine	  was	  first	  recommended	  for	  all	  children	  in	  1999,	  and	  the	  rotavirus	  vaccine	  was	  recommended	  for	  all	  children	  in	  2008.	  	  The	  varicella	  vaccine,	  which	  also	  was	  introduced	  relatively	  recently,	  is	  often	  combined	  with	  the	  MMR	  vaccine,	  possibly	  leading	  to	  higher	  coverage	  rates	  for	  such	  a	  new	  vaccine.	  
 
5.6	  Limitations	  and	  Recommendations	  	   This	  study	  looked	  only	  at	  data	  from	  the	  2010	  National	  Immunization	  Survey;	  therefore	  trends	  over	  time	  cannot	  be	  seen.	  	  It	  would	  be	  useful	  to	  conduct	  similar	  analysis	  on	  data	  from	  previous	  years	  in	  order	  to	  examine	  to	  what	  extent	  programs	  have	  helped	  to	  eliminate	  disparities	  in	  immunization	  status.	  	  Additionally,	  as	  data	  used	  were	  not	  weighted,	  results	  cannot	  be	  extrapolated	  to	  the	  general	  population.	  	  Although	  data	  were	  analyzed	  for	  respondents	  from	  Georgia	  and	  from	  the	  United	  States	  as	  a	  whole,	  direct	  comparisons	  between	  the	  two	  populations	  may	  not	  be	  possible	  since	  weighted	  data	  were	  not	  used.	  	  Further	  research	  could	  also	  investigate	  what,	  if	  any,	  other	  factors	  are	  useful	  in	  determining	  up-­‐to-­‐date	  immunization	  status;	  this	  could	  facilitate	  improvements	  in	  existing	  programs	  and	  interventions.	  	   Immunization	  rates	  have	  been	  improving	  recently	  across	  all	  populations	  in	  the	  United	  States	  (Joyce	  &	  Racine,	  2005).	  	  Although	  the	  direct	  effect	  of	  programs	  such	  as	  SCHIP	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and	  VFC	  on	  immunization	  rates	  is	  as	  yet	  unknown,	  it	  can	  be	  assumed	  that	  there	  has	  been	  some	  positive	  impact.	  	  One	  sign	  of	  this	  is	  that	  alternate	  provider	  referrals	  for	  vaccines	  decrease	  when	  VFC	  participation	  increases	  (Zimmerman,	  et	  al.,	  2006).	  	  Therefore,	  despite	  the	  continued	  associations	  between	  insurance	  type	  and	  continuity	  and	  up-­‐to-­‐date	  immunization	  status,	  it	  does	  not	  seem	  reasonable	  to	  assume	  that	  programs	  in	  place	  are	  ineffective.	  	  Rather,	  it	  seems	  they	  could	  be	  improved	  and	  better-­‐utilized	  in	  order	  to	  maximize	  the	  benefits.	  	   One	  way	  to	  improve	  immunization	  coverage	  among	  children	  who	  have	  public	  insurance,	  are	  eligible	  for	  the	  Vaccines	  for	  Children	  program,	  or	  have	  experienced	  gaps	  in	  health	  insurance	  coverage	  is	  to	  increase	  provider	  participation	  in	  the	  VFC	  program.	  	  The	  inverse	  association	  between	  provider	  referrals	  for	  vaccines	  and	  vaccine	  receipt	  has	  been	  well	  documented.	  	  Participation	  in	  the	  VFC	  program	  can	  reduce	  provider	  referrals	  by	  making	  available	  free	  vaccines	  for	  providers	  to	  give	  to	  qualifying	  children,	  which	  can	  in	  turn	  lead	  to	  improved	  access	  to	  vaccines	  (GA	  DPH,	  2010;	  Zimmerman,	  et	  al.,	  2006).	  	  Decreased	  provider	  referrals	  will	  also	  serve	  to	  facilitate	  better	  record	  keeping,	  which	  in	  turn	  will	  also	  help	  to	  increase	  immunization	  rates.	  	  Among	  the	  2010	  NIS	  participants,	  shot	  cards	  were	  reportedly	  available	  for	  fewer	  than	  27	  percent	  of	  children.	  	  For	  30	  percent	  of	  children,	  provider	  data	  was	  insufficient	  to	  determine	  up-­‐to-­‐date	  immunization	  status	  (DHHS	  &	  NCHS,	  2011).	  	  Research	  has	  shown	  that	  having	  inadequate	  or	  inaccessible	  immunization	  records	  can	  be	  a	  barrier	  to	  childhood	  immunization	  (Deutchman,	  Brayden,	  Siegel,	  Beaty,	  &	  Crane,	  2000);	  complete	  and	  readily	  accessible	  records	  will	  facilitate	  immunization	  uptake.	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   Improving	  interactions	  with	  parents	  will	  also	  serve	  to	  increase	  immunization	  rates.	  	  This	  should	  be	  done	  in	  two	  ways:	  by	  taking	  advantage	  of	  sick-­‐child	  visits	  to	  give	  vaccines	  whenever	  possible,	  and	  by	  communicating	  more	  effectively	  to	  parents	  the	  importance	  of	  ensuring	  children	  receive	  all	  appropriate	  vaccines.	  	  Immunizing	  children	  during	  sick-­‐child	  visits	  has	  been	  previously	  recommended	  and	  should	  be	  taken	  into	  consideration	  whenever	  possible.	  	  Parents	  report	  that	  sick-­‐child	  health	  care	  is	  more	  accessible	  than	  well-­‐child	  care,	  and	  parents	  are	  more	  likely	  to	  skip	  well-­‐care	  appointments	  for	  economic	  or	  transportation	  reasons	  (Deutchman,	  Brayden,	  Siegel,	  Beaty,	  &	  Crane,	  2000;	  McCormick,	  Bartholomew,	  Lewis,	  Brown,	  &	  Hanson,	  1997).	  	  Not	  all	  vaccines	  can	  be	  given	  when	  a	  child	  is	  ill;	  however,	  once	  a	  child	  is	  present	  in	  a	  physician’s	  office	  or	  clinic,	  the	  opportunity	  can	  be	  taken	  to	  plan	  follow-­‐up	  visits	  at	  which	  vaccines	  may	  be	  given.	  	  This	  would	  help	  to	  address	  some	  of	  the	  continued	  differences	  in	  immunization	  rates	  caused	  by	  economic	  and	  systemic	  barriers.	  Improving	  communication	  between	  public	  health	  practitioners,	  health	  care	  providers,	  and	  parents	  would	  further	  increase	  immunization	  rates.	  	  Previous	  studies	  have	  reported	  that	  parents	  often	  have	  little	  understanding	  of	  the	  importance	  of	  vaccines	  and	  that	  even	  well-­‐informed	  providers	  are	  not	  always	  able	  to	  translate	  that	  knowledge	  into	  improving	  vaccination	  coverage	  among	  patients	  (McCormick,	  Bartholomew,	  Lewis,	  Brown,	  &	  Hanson,	  1997;	  Thomas,	  Kohli,	  &	  King,	  2004).	  	  As	  mother’s	  education	  was	  found	  in	  this	  analysis	  to	  be	  an	  important	  predictor	  of	  up-­‐to-­‐date	  status	  in	  some	  cases,	  it	  seems	  that	  providers	  and	  practitioners	  could	  be	  doing	  a	  better	  job	  of	  assisting	  parents	  in	  making	  informed	  decisions	  regarding	  immunizations	  for	  their	  children.	  	  Creating	  a	  rapport	  between	  providers	  and	  parents	  can	  also	  help	  in	  establishing	  a	  permanent	  medical	  home	  for	  a	  child.	  	  All	  of	  these	  factors,	  when	  targeted	  separately	  and	  especially	  when	  taken	  together,	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can	  lead	  to	  increased	  opportunities	  for	  immunizations,	  reduced	  impact	  of	  health	  insurance	  status,	  and	  overall	  improved	  health	  outcomes	  for	  children.	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